Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
21000,Not Active,5085168,CHEMBL1637775,Antibacterial activity against Bacillus anthracis spores assessed as reduction in membrane potential at 0.01 uM,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21001,Not Active,5085169,CHEMBL1637776,Antibacterial activity against Bacillus anthracis spores assessed as reduction in membrane potential at 0.1 uM,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21002,Not Active,5085170,CHEMBL1637777,Antibacterial activity against Bacillus anthracis spores assessed as reduction in membrane potential at 1 uM,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21003,Not Active,5085171,CHEMBL1637778,Antibacterial activity against Bacillus anthracis spores assessed as reduction in membrane potential at 10 uM,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21004,Active,5085179,CHEMBL1637786,Antibacterial activity against Bacillus anthracis spores assessed as loss of membrane integrity at 0.01 uM by flow cytometry relative to control,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21005,Active,5085180,CHEMBL1637779,Antibacterial activity against Bacillus anthracis spores assessed as loss of membrane integrity at 0.1 uM by flow cytometry relative to control,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21006,Active,5085181,CHEMBL1637780,Antibacterial activity against Bacillus anthracis spores assessed as loss of membrane integrity at 1 uM by flow cytometry relative to control,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21007,Active,5085182,CHEMBL1637781,Antibacterial activity against Bacillus anthracis spores assessed as loss of membrane integrity at 10 uM by flow cytometry relative to control,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629561,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312960,,1,0,,Activity,,,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,,,
21008,,5085966,CHEMBL1634884,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80, G84 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,300.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,300.0
21009,,5085968,CHEMBL1634883,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,40.0
21010,,5085969,CHEMBL1634882,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
21011,,5085970,CHEMBL1634881,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
21012,,5085971,CHEMBL1634880,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC K84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,500.0
21013,,5085972,CHEMBL1634879,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
21014,,5085973,CHEMBL1634878,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83,N87,gyrB V456, parC I80 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
21015,,5085974,CHEMBL1634877,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80, K84 and parE D460 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
21016,,5085975,CHEMBL1634876,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, gyrB T471 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
21017,,5085976,CHEMBL1634875,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC R80, V84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,500.0
21018,,5085977,CHEMBL1634874,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
21019,,5085978,CHEMBL1634873,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE A548 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
21020,,5085979,CHEMBL1634872,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE M464 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
21021,,5085980,CHEMBL1634871,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
21022,,5085981,CHEMBL1634870,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC K84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
21023,,5085982,CHEMBL1634869,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
21024,,5085983,CHEMBL1634866,Antimicrobial activity against Escherichia coli K-12 harboring gyrA A83 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.094
21025,,5085984,CHEMBL1634868,Antimicrobial activity against Escherichia coli K-12 harboring parE A458 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
21026,,5085985,CHEMBL1634867,Antimicrobial activity against Escherichia coli K-12 harboring by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313900,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21027,,5085992,CHEMBL1634885,Antimicrobial activity against Escherichia coli ATCC 25922 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313904,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21028,,5085993,CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313904,=,1,1,=,MIC,ug.mL-1,0.017,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.017
21029,,5085994,CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313904,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21030,,5085995,CHEMBL1634887,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313904,=,1,1,=,MIC,ug.mL-1,85.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,85.0
21031,,5085997,CHEMBL1634888,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313904,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
21032,,5086037,CHEMBL1635036,Antimicrobial activity against Nocardia brasiliensis HUJEG-1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629568,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313910,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC,ug ml-1,UO_0000274,4.0
21033,,5086038,CHEMBL1635036,Antimicrobial activity against Nocardia brasiliensis HUJEG-1 by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629568,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313910,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC50,ug ml-1,UO_0000274,4.0
21034,,5086039,CHEMBL1635036,Antimicrobial activity against Nocardia brasiliensis HUJEG-1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629568,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313910,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC90,ug ml-1,UO_0000274,64.0
21035,,5086050,CHEMBL1633249,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313918,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,4.0
21036,,5086059,CHEMBL1633250,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as susceptible isolates,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313918,=,1,0,=,Activity,%,96.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,96.0
21037,,5086068,CHEMBL1633251,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313918,=,1,0,=,Activity,%,124.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,124.0
21038,,5086077,CHEMBL1633249,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629569,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313918,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,4.0
21039,,5086639,CHEMBL1633263,Antimicrobial activity against Klebsiella pneumoniae C1 expressing aac(6')-Ib-cr gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
21040,,5086640,CHEMBL1633264,Antimicrobial activity against Klebsiella pneumoniae C7 expressing aac(6')-Ib-cr gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
21041,,5086641,CHEMBL1633265,"Antimicrobial activity against Klebsiella pneumoniae D10 expressing aac(6')-Ib-cr, qnrB4, CTX-M-1G and DHA-1 genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21042,,5086642,CHEMBL1633266,"Antimicrobial activity against Klebsiella pneumoniae D20 expressing aac(6')-Ib-cr, CTX-M-9G and DHA-1 genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21043,,5086643,CHEMBL1633267,Antimicrobial activity against Klebsiella pneumoniae D24 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
21044,,5086644,CHEMBL1633268,"Antimicrobial activity against Klebsiella pneumoniae D34 expressing aac(6')-Ib-cr, qepA and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21045,,5086645,CHEMBL1633269,Antimicrobial activity against Klebsiella pneumoniae D61 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
21046,,5086646,CHEMBL1633270,Antimicrobial activity against Enterobacter cloacae D32 expressing qepA and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
21047,,5086647,CHEMBL1633271,Antimicrobial activity against Enterobacter cloacae D73 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,16.0
21048,,5086648,CHEMBL1633272,Antimicrobial activity against Citrobacter freundii D26 expressing qnrB6 and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,4.0
21049,,5086649,CHEMBL1633273,"Antimicrobial activity against Escherichia coli D3 expressing aac(6')-Ib-cr, qepA, CTX-M-1G and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21050,,5086650,CHEMBL1633274,"Antimicrobial activity against Escherichia coli D23 expressing aac(6')-Ib-cr, qepA and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21051,,5086651,CHEMBL1633275,"Antimicrobial activity against Escherichia coli D40 expressing qepA, CTX-M-1G and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
21052,,5086652,CHEMBL1633276,"Antimicrobial activity against Escherichia coli D47 expressing aac(6')-Ib-cr, qepA and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21053,,5086653,CHEMBL1633277,Antimicrobial activity against Escherichia coli D55 expressing qepA and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21054,,5086654,CHEMBL1633278,Antimicrobial activity against Escherichia coli D57 expressing qepA and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
21055,,5086655,CHEMBL1633279,"Antimicrobial activity against Escherichia coli D60 expressing qepA, CTX-M-1G and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21056,,5086656,CHEMBL1633280,Antimicrobial activity against Escherichia coli D61 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21057,,5086657,CHEMBL1633281,Antimicrobial activity against Escherichia coli D76 expressing qepA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21058,,5086658,CHEMBL1633282,"Antimicrobial activity against Escherichia coli D71 expressing qepA, CTX-M-1G and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
21059,,5086659,CHEMBL1633283,Antimicrobial activity against Escherichia coli D77 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
21060,,5086660,CHEMBL1633284,"Antimicrobial activity against Escherichia coli D81 expressing aac(6')-Ib-cr, CMY-2 and CTX-M-9G genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21061,,5086661,CHEMBL1633285,Antimicrobial activity against Escherichia coli D86 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
21062,,5086662,CHEMBL1633286,Antimicrobial activity against Escherichia coli D87 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21063,,5086663,CHEMBL1633287,Antimicrobial activity against Escherichia coli Du6 expressing qnrB6 and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
21064,,5086664,CHEMBL1633288,Antimicrobial activity against Escherichia coli Du27 expressing qepA and CTX-M-1G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21065,,5086665,CHEMBL1633434,Antimicrobial activity against Escherichia coli Du19 expressing qnrB6 and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
21066,,5086666,CHEMBL1633435,Antimicrobial activity against Escherichia coli Du89 expressing qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21067,,5086667,CHEMBL1633436,Antimicrobial activity against Escherichia coli P1 expressing qepA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21068,,5086668,CHEMBL1633437,Antimicrobial activity against Escherichia coli P17 expressing qepA and CTX-M-1G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21069,,5086669,CHEMBL1633438,Antimicrobial activity against Escherichia coli P498 expressing qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
21070,,5086670,CHEMBL1633439,Antimicrobial activity against Escherichia coli Chi197 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
21071,,5086671,CHEMBL1633440,Antimicrobial activity against Escherichia coli PA09 expressing aac(6')-Ib-cr gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
21072,,5086672,CHEMBL1633441,"Antimicrobial activity against Escherichia coli PA11 expressing aac(6')-Ib-cr, qnrS1 and qepA genes by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
21073,,5086673,CHEMBL1633442,Antimicrobial activity against Escherichia coli PA14 expressing aac(6')-Ib-cr and qepA genes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
21074,,5086674,CHEMBL1633449,Antimicrobial activity against Escherichia coli J53 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
21075,,5086675,CHEMBL1633450,"Antimicrobial activity against Klebsiella pneumoniae D10 expressing aac(6')-Ib-cr, qnrB4, CTX-M-1G and DHA-1 genes by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21076,,5086676,CHEMBL1633451,Antimicrobial activity against Escherichia coli J53 transformed with pHND1 carrying DHA-1 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21077,,5086677,CHEMBL1633452,Antimicrobial activity against Klebsiella pneumoniae D24 expressing aac(6')-Ib-cr and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
21078,,5086678,CHEMBL1633453,Antimicrobial activity against Escherichia coli J53 transformed with pHND2 carrying qnrB6 and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21079,,5086679,CHEMBL1633454,Antimicrobial activity against Citrobacter freundii D26 expressing qnrB6 and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,4.0
21080,,5086680,CHEMBL1633455,Antimicrobial activity against Escherichia coli J53 transformed with pHND3 carrying qnrB6 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
21081,,5086681,CHEMBL1633456,Antimicrobial activity against Escherichia coli Du19 expressing qnrB6 and CTX-M-9G genes by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21082,,5086682,CHEMBL1633457,Antimicrobial activity against Escherichia coli J53 transformed with pHNDU1 carrying qnrB6 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21083,,5086683,CHEMBL1633458,"Antimicrobial activity against Escherichia coli PA11 expressing aac(6')-Ib-cr, qnrS1 and qepA genes by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
21084,,5086684,CHEMBL1634250,Antimicrobial activity against Escherichia coli J53 transformed with pHNPA1 carrying qnrB6 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629571,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313923,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21085,,5087002,CHEMBL1637064,Antimicrobial activity against fluoroquinolone-susceptible Neisseria meningitidis by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629607,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1315097,=,1,1,=,IZ,mm,34.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,IZ,mm,UO_0000016,34.0
21086,,5087003,CHEMBL1637178,Antimicrobial activity against fluoroquinolone-intermediate Neisseria meningitidis by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629607,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315097,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,mg/L,UO_0000274,0.06
21087,,5087004,CHEMBL1637178,Antimicrobial activity against fluoroquinolone-intermediate Neisseria meningitidis by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629607,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1315097,=,1,1,=,IZ,mm,35.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,IZ,mm,UO_0000016,35.0
21088,,5087005,CHEMBL1637179,Antimicrobial activity against fluoroquinolone-resistant Neisseria meningitidis expressing gyrA mutant by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629607,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315097,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,mg/L,UO_0000274,0.12
21089,,5087006,CHEMBL1637179,Antimicrobial activity against fluoroquinolone-resistant Neisseria meningitidis expressing gyrA mutant by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629607,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1315097,=,1,1,=,IZ,mm,29.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,IZ,mm,UO_0000016,29.0
21090,,5087007,CHEMBL1637064,Antimicrobial activity against fluoroquinolone-susceptible Neisseria meningitidis by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629607,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315097,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,mg/L,UO_0000274,0.03
21091,,5089074,CHEMBL1637272,Antimicrobial activity against Klebsiella pneumoniae 52145,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629613,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312995,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.05
21092,,5089079,CHEMBL1637398,Antimicrobial activity against Klebsiella pneumoniae 52OmpA2Com,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629613,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312995,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.04
21093,Not Determined,5089084,CHEMBL1637399,Antimicrobial activity against Klebsiella pneumoniae 52OmpA2,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629613,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312995,,1,0,,MIC,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,,,
21094,,5089268,CHEMBL1635003,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0005
21095,,5089269,CHEMBL1635002,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG298 carrying SOS-regulated qnrB1 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21096,,5089270,CHEMBL1635004,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.001
21097,,5089271,CHEMBL1635006,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
21098,,5089272,CHEMBL1635007,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21099,,5089273,CHEMBL1635008,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG298 carrying SOS-regulated qnrB1 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
21100,,5089274,CHEMBL1635009,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG298 carrying SOS-regulated qnrB1 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
21101,,5089275,CHEMBL1635010,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG298 carrying SOS-regulated qnrB1 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
21102,,5089276,CHEMBL1635011,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG301 carrying SOS-regulated qnrB2 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.003
21103,,5089277,CHEMBL1635012,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG301 carrying SOS-regulated qnrB2 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
21104,,5089278,CHEMBL1635013,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG301 carrying SOS-regulated qnrB2 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
21105,,5089279,CHEMBL1635014,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG301 carrying SOS-regulated qnrB2 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
21106,,5089280,CHEMBL1635015,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG317 carrying SOS-regulated qnrB3 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.094
21107,,5089281,CHEMBL1635144,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG317 carrying SOS-regulated qnrB3 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21108,,5089282,CHEMBL1635145,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG317 carrying SOS-regulated qnrB3 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21109,,5089283,CHEMBL1635146,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG317 carrying SOS-regulated qnrB3 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
21110,,5089284,CHEMBL1635147,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG320 carrying SOS-regulated qnrB5 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
21111,,5089285,CHEMBL1635148,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG320 carrying SOS-regulated qnrB5 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
21112,,5089286,CHEMBL1635149,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG320 carrying SOS-regulated qnrB5 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
21113,,5089287,CHEMBL1635150,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG320 carrying SOS-regulated qnrB5 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.094
21114,,5089288,CHEMBL1635151,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG252 carrying qnrA1 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
21115,,5089289,CHEMBL1635152,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG252 carrying qnrA1 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
21116,,5089290,CHEMBL1635153,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG252 carrying qnrA1 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
21117,,5089291,CHEMBL1635154,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG252 carrying qnrA1 gene at 40 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
21118,,5089292,CHEMBL1635155,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG306 carrying qnrS1 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
21119,,5089293,CHEMBL1635156,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG306 carrying qnrS1 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.094
21120,,5089294,CHEMBL1633592,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG306 carrying qnrS1 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21121,,5089295,CHEMBL1633393,Antimicrobial activity against lexA- and recA441- positive Escherichia coli GW1000 harboring pMG306 carrying qnrS1 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21122,,5089296,CHEMBL1635005,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG298 carrying SOS-regulated qnrB1 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
21123,,5089297,CHEMBL1633394,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG298 carrying SOS-regulated qnrB1 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21124,,5089298,CHEMBL1633395,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG298 carrying SOS-regulated qnrB1 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21125,,5089299,CHEMBL1633396,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG298 carrying SOS-regulated qnrB1 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21126,,5089300,CHEMBL1633397,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21127,,5089301,CHEMBL1633398,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
21128,,5089302,CHEMBL1633399,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
21129,,5089303,CHEMBL1633400,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
21130,,5089304,CHEMBL1633401,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG252 carrying qnrA1 gene at 21 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
21131,,5090013,CHEMBL1633402,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG252 carrying qnrA1 gene at 30 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21132,,5090014,CHEMBL1633403,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG252 carrying qnrA1 gene at 37 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21133,,5090015,CHEMBL1633404,Antimicrobial activity against lexA- and recA- positive Escherichia coli J53 harboring pMG252 carrying qnrA1 gene at 43 degC,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314549,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21134,,5090016,CHEMBL1633405,Induction of qnrB1 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 15 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,3.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,3.7
21135,,5090017,CHEMBL1633406,Induction of qnrB1 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,3.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,3.2
21136,,5090020,CHEMBL1633409,Induction of qnrB2 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,5.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,5.9
21137,,5090021,CHEMBL1633410,Induction of qnrB3 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,2.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.1
21138,,5090022,CHEMBL1633411,Induction of qnrB4 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 15 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,9.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,9.9
21139,,5090023,CHEMBL1633412,Induction of qnrB4 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,9.0
21140,,5090026,CHEMBL1633415,Induction of qnrA1 gene expression in lexA- and recA- positive Escherichia coli J53 at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,0.9
21141,,5090028,CHEMBL1633417,Induction of qnrB4 gene expression in lexA- and recA- positive Escherichia coli AB1157 at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,3.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,3.9
21142,,5090030,CHEMBL1633419,Induction of qnrB4 gene expression in recA-positive Escherichia coli AB1157 expressing deffective lexA gene at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,1.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.1
21143,,5090032,CHEMBL1633421,Induction of qnrB4 gene expression in recA-positive Escherichia coli DM49 expressing protease-resistant lexA at 0.1 ug/ml after 30 mins by quantitative PCR method relative to control,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629618,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1314549,=,1,0,=,FC,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,1.2
21144,,5090034,CHEMBL1633423,Antimicrobial activity against Salmonella enterica serovar Kentucky by broth microdilution assay,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
21145,,5090044,CHEMBL1633429,Antimicrobial activity against Escherichia coli DH10B by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
21146,,5090045,CHEMBL1633430,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
21147,,5090046,CHEMBL1633431,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrA1 gene by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21148,,5090047,CHEMBL1633432,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrS1 gene by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21149,,5090048,CHEMBL1633433,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrD gene by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
21150,,5090049,CHEMBL1633573,Antimicrobial activity against Escherichia coli DH10B harboring p2007057 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314551,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21151,,5091059,CHEMBL1637187,Antimicrobial activity against Enterococcus faecalis NKH1 harboring pMG2200-like plasmid after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21152,,5091060,CHEMBL1637188,Antimicrobial activity against Enterococcus faecalis NKH2 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21153,,5091061,CHEMBL1637189,Antimicrobial activity against Enterococcus faecalis NKH3 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21154,,5091062,CHEMBL1637190,Antimicrobial activity against Enterococcus faecalis NKH4 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21155,,5091063,CHEMBL1637191,Antimicrobial activity against Enterococcus faecalis NKH5 harboring pMG2200-like plasmid after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21156,,5091064,CHEMBL1637192,Antimicrobial activity against Enterococcus faecalis NKH6 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21157,,5091065,CHEMBL1637193,Antimicrobial activity against Enterococcus faecalis NKH7 harboring pMG2200-like plasmid after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21158,,5091066,CHEMBL1637194,Antimicrobial activity against Enterococcus faecalis NKH8 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21159,,5091067,CHEMBL1637195,Antimicrobial activity against Enterococcus faecalis NKH9 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21160,,5091068,CHEMBL1637196,Antimicrobial activity against Enterococcus faecalis NKH10 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21161,,5091069,CHEMBL1637197,Antimicrobial activity against Enterococcus faecalis NKH11 harboring pMG2200-like plasmid after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21162,,5091070,CHEMBL1637198,Antimicrobial activity against Enterococcus faecalis NKH12 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21163,,5091071,CHEMBL1637199,Antimicrobial activity against Enterococcus faecalis NKH13 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21164,,5091072,CHEMBL1637200,Antimicrobial activity against Enterococcus faecalis NKH14 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21165,,5091073,CHEMBL1637201,Antimicrobial activity against Enterococcus faecalis NKH15 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21166,,5091074,CHEMBL1637202,Antimicrobial activity against Enterococcus faecalis NKH16 harboring pMG2200-like plasmid after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21167,,5091075,CHEMBL1637203,Antimicrobial activity against Enterococcus faecalis NKH17 harboring pMG2200-like plasmid after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21168,,5091180,CHEMBL1637204,Antimicrobial activity against Enterococcus faecalis NKH18 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629622,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314584,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,64.0
21169,Not Active,5091341,CHEMBL1637576,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ043 from patient abdominal drainage by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21170,Not Active,5091342,CHEMBL1637577,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ068 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21171,Not Active,5091343,CHEMBL1637578,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ078 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21172,Not Active,5091344,CHEMBL1637579,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ082 from patient bile by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21173,Not Active,5091345,CHEMBL1637580,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ085 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21174,Not Active,5091346,CHEMBL1637581,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ088 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21175,Not Active,5091347,CHEMBL1637582,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ210 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21176,Not Active,5091348,CHEMBL1637583,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ249 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21177,Not Active,5091349,CHEMBL1637584,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ250 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21178,Not Active,5091350,CHEMBL1637585,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ274 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21179,Not Active,5091351,CHEMBL1637586,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ363 from patient secretion by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21180,Not Active,5091352,CHEMBL1637587,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ372 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21181,Not Active,5091353,CHEMBL1637588,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ390 from patient secretion by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21182,Not Active,5091354,CHEMBL1637589,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate CC023 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21183,Not Active,5091355,CHEMBL1637590,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate DL010 from patient sputum by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21184,Not Active,5091356,CHEMBL1637591,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate SZ009 from patient pus by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629625,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1315132,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
21185,,5092224,CHEMBL1634553,Antimicrobial activity against quinolone-resistant Escherichia coli by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629632,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315302,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21186,,5094703,CHEMBL1634067,fT>MIC in Bacillus anthracis infected in vitro hollow fiber PK/PD model at simulated dose of 400 mg administered every 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629546,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,1314730,=,1,0,=,fT>MIC,hr,17.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,fT>MIC,hr,UO_0000032,17.0
21187,,5094820,CHEMBL1635254,Antimicrobial activity against Aeromonas hydrophila assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,90.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,Activity,%,UO_0000187,90.0
21188,,5094821,CHEMBL1635255,Antimicrobial activity against Aeromonas caviae assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,86.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,Activity,%,UO_0000187,86.0
21189,,5094822,CHEMBL1635256,Antimicrobial activity against Aeromonas sobria assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,93.0,CHEMBL614400,Aeromonas sobria,Aeromonas sobria,646.0,,Activity,%,UO_0000187,93.0
21190,,5094823,CHEMBL1635257,Antimicrobial activity against Salmonella serotype Choleraesuis assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,22.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,Activity,%,UO_0000187,22.0
21191,,5094824,CHEMBL1635258,Antimicrobial activity against Salmonella serogroup O7 assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,77.0,CHEMBL614446,Salmonella,Salmonella,590.0,,Activity,%,UO_0000187,77.0
21192,,5094825,CHEMBL1633486,Antimicrobial activity against Salmonella serogroup O8 assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,57.0,CHEMBL614446,Salmonella,Salmonella,590.0,,Activity,%,UO_0000187,57.0
21193,,5094826,CHEMBL1633487,Antimicrobial activity against Salmonella serogroup O9 assessed as susceptibility level by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629548,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1314735,=,1,0,=,Activity,%,96.0,CHEMBL614446,Salmonella,Salmonella,590.0,,Activity,%,UO_0000187,96.0
21194,,5094954,CHEMBL1633206,Antibacterial activity against Klebsiella pneumoniae A expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.38
21195,,5094955,CHEMBL1633204,Antibacterial activity against Klebsiella pneumoniae B expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21196,,5094956,CHEMBL1633205,Antibacterial activity against Klebsiella pneumoniae C expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21197,,5094957,CHEMBL1633203,Antibacterial activity against Klebsiella pneumoniae D expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21198,,5094958,CHEMBL1633201,Antibacterial activity against Klebsiella pneumoniae expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.032
21199,,5094959,CHEMBL1633206,Antibacterial activity against Klebsiella pneumoniae A expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,1.0
21200,,5094960,CHEMBL1633204,Antibacterial activity against Klebsiella pneumoniae B expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,32.0
21201,,5094961,CHEMBL1633205,Antibacterial activity against Klebsiella pneumoniae C expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,32.0
21202,,5094962,CHEMBL1633203,Antibacterial activity against Klebsiella pneumoniae D expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,32.0
21203,,5094963,CHEMBL1633201,Antibacterial activity against Klebsiella pneumoniae expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,16.0
21204,,5094964,CHEMBL1633206,Antibacterial activity against Klebsiella pneumoniae A expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,=,1,1,=,MIC90,ug.mL-1,6.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,6.0
21205,,5094965,CHEMBL1633204,Antibacterial activity against Klebsiella pneumoniae B expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
21206,,5094966,CHEMBL1633205,Antibacterial activity against Klebsiella pneumoniae C expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
21207,,5094967,CHEMBL1633203,Antibacterial activity against Klebsiella pneumoniae D expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
21208,,5094968,CHEMBL1633201,Antibacterial activity against Klebsiella pneumoniae expressing CTX-M group 1 beta-lactamase by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,32.0
21209,,5095021,CHEMBL1635692,Antibacterial activity against rifampicin resistant Escherichia coli J53-2 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21210,,5095053,CHEMBL1635690,Antibacterial activity against Escherichia coli TrC A expressing Klebsiella pneumoniae A blaCTX-M beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21211,,5095054,CHEMBL1635687,Antibacterial activity against Escherichia coli TrC B expressing Klebsiella pneumoniae B blaCTX-M beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21212,,5095055,CHEMBL1633392,Antibacterial activity against Escherichia coli TrC C expressing Klebsiella pneumoniae C blaCTX-M beta-lactamase by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314365,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21213,,5096043,CHEMBL1635207,Antimicrobial activity against Acinetobacter radioresistens 251-39C expressing beta-lactamase OXA-133 by CLSI method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629591,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314515,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL2366968,Acinetobacter radioresistens,Acinetobacter radioresistens,40216.0,,MIC,ug ml-1,UO_0000274,0.06
21214,,5096044,CHEMBL1635208,Antimicrobial activity against plasmid encoded beta-lactamase OXA-58 deficient Acinetobacter radioresistens by CLSI method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629591,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314515,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL2366968,Acinetobacter radioresistens,Acinetobacter radioresistens,40216.0,,MIC,ug ml-1,UO_0000274,0.12
21215,,5096324,CHEMBL1634796,Antiproliferative activity against Theileria parva-induced proliferation of bovine B lymphocyte assessed as inhibition of [3H]thymidine uptake after 48 hrs,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629644,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1315497,=,1,1,=,IC50,nM,123000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,uM,UO_0000065,123.0
21216,,5096333,CHEMBL1634792,Induction of apoptosis in bovine BL3 cells assessed as early apoptotic cells after 24 hrs by annexin V/propidium iodide staining-based FACS analysis,F,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629644,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315497,=,1,0,=,Activity,%,1.03,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,1.03
21217,,5096334,CHEMBL1634793,Induction of apoptosis in bovine BL3 cells assessed as viable cells after 24 hrs by annexin V/propidium iodide staining-based FACS analysis,F,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629644,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315497,=,1,0,=,Activity,%,98.63,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,98.63
21218,,5096335,CHEMBL1634794,Induction of apoptosis in bovine BL3 cells assessed as late apoptotic cells after 24 hrs by annexin V/propidium iodide staining-based FACS analysis,F,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629644,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315497,=,1,0,=,Activity,%,0.25,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,0.25
21219,,5096336,CHEMBL1634795,Induction of apoptosis in bovine BL3 cells assessed as necrotic after 24 hrs by annexin V/propidium iodide staining-based FACS analysis,F,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629644,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315497,=,1,0,=,Activity,%,0.03,CHEMBL612545,,Unchecked,,,Activity,%,UO_0000187,0.03
21220,,5096800,CHEMBL1636726,Antimicrobial activity against Pseudomonas aeruginosa Xen 5 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 2000 microamperes of electric current by bioelectric effect assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312940,=,1,0,=,log10cfu,,1.86,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,1.86
21221,,5096803,CHEMBL1636725,Antimicrobial activity against Pseudomonas aeruginosa Xen 5 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1312940,=,1,0,=,log10cfu,,-0.63,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,-0.63
21222,,5096822,CHEMBL1635871,Antimicrobial activity against Pseudomonas aeruginosa Xen 5 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312940,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
21223,,5096825,CHEMBL1636921,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21224,,5096826,CHEMBL1636920,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21225,,5096827,CHEMBL1636918,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21226,,5096828,CHEMBL1636917,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21227,,5096829,CHEMBL1636916,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21228,,5096854,CHEMBL1636919,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21229,,5096872,CHEMBL1636739,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,25.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,25.0
21230,,5096873,CHEMBL1636735,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,25.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,25.0
21231,,5096879,CHEMBL1636746,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,24.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,24.0
21232,,5096885,CHEMBL1636742,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,23.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,23.0
21233,,5096886,CHEMBL1636740,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,23.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,23.0
21234,,5096887,CHEMBL1636737,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,23.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,23.0
21235,,5096895,CHEMBL1636741,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,22.0
21236,,5096903,CHEMBL1636738,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
21237,,5096904,CHEMBL1636736,Antibacterial activity against Streptococcus pneumoniae R6 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
21238,,5096913,CHEMBL1636745,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,19.0
21239,,5096914,CHEMBL1636744,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,19.0
21240,,5096938,CHEMBL1636747,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,13.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,13.0
21241,,5096939,CHEMBL1636743,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,13.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,13.0
21242,,5096945,CHEMBL1636748,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1312950,=,1,1,=,IZ,mm,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,10.0
21243,,5096958,CHEMBL1636915,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
21244,,5096959,CHEMBL1636911,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312950,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
21245,,5099530,CHEMBL1640892,Antimicrobial activity against Pseudomonas aeruginosa isolate 243-31C expressing beta-lactamase VIM-18 isolated from sputum of patient by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313030,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.06
21246,Not Determined,5099590,CHEMBL1641040,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-18 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1313030,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
21247,Not Determined,5099591,CHEMBL1641041,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-2 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1313030,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
21248,Not Determined,5099592,CHEMBL1641042,Antimicrobial activity against Escherichia coli harboring plasmid pPCRScript by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1313030,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
21249,,5099621,CHEMBL1640374,Antibacterial activity against Campylobacter coli assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,16.5,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,Activity,%,UO_0000187,16.5
21250,,5099625,CHEMBL1640373,Antibacterial activity against Campylobacter coli assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,82.6,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,Activity,%,UO_0000187,82.6
21251,,5099634,CHEMBL1640372,Antibacterial activity against Campylobacter coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,>,1,1,>,MIC90,ug.mL-1,2.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC90,ug ml-1,UO_0000274,2.0
21252,,5099640,CHEMBL1640372,Antibacterial activity against Campylobacter coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,MIC50,ug ml-1,UO_0000274,0.06
21253,,5099646,CHEMBL1640371,Antibacterial activity against Campylobacter jejuni assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,16.5,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,Activity,%,UO_0000187,16.5
21254,,5099651,CHEMBL1640241,Antibacterial activity against Campylobacter jejuni assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,82.6,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,Activity,%,UO_0000187,82.6
21255,,5099660,CHEMBL1640240,Antibacterial activity against Campylobacter jejuni by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,>,1,1,>,MIC90,ug.mL-1,2.0,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC90,ug ml-1,UO_0000274,2.0
21256,,5099665,CHEMBL1640240,Antibacterial activity against Campylobacter jejuni by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,MIC50,ug ml-1,UO_0000274,0.06
21257,,5099681,CHEMBL1640237,Antibacterial activity against Vibrio sp. by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL613175,Vibrio sp.,Vibrio sp.,678.0,,MIC90,ug ml-1,UO_0000274,0.06
21258,,5099687,CHEMBL1640237,Antibacterial activity against Vibrio sp. by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL613175,Vibrio sp.,Vibrio sp.,678.0,,MIC50,ug ml-1,UO_0000274,0.016
21259,,5099693,CHEMBL1640237,Antibacterial activity against Vibrio sp. by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL613175,Vibrio sp.,Vibrio sp.,678.0,,MIC,ug ml-1,UO_0000274,0.001
21260,,5100787,CHEMBL1640234,Antibacterial activity against Vibrio vulnificus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614404,Vibrio vulnificus,Vibrio vulnificus,672.0,,MIC90,ug ml-1,UO_0000274,0.06
21261,,5100793,CHEMBL1640234,Antibacterial activity against Vibrio vulnificus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL614404,Vibrio vulnificus,Vibrio vulnificus,672.0,,MIC50,ug ml-1,UO_0000274,0.016
21262,,5100799,CHEMBL1640234,Antibacterial activity against Vibrio vulnificus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL614404,Vibrio vulnificus,Vibrio vulnificus,672.0,,MIC,ug ml-1,UO_0000274,0.001
21263,,5100811,CHEMBL1640231,Antibacterial activity against Vibrio fluvialis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614602,Vibrio fluvialis,Vibrio fluvialis,676.0,,MIC90,ug ml-1,UO_0000274,0.06
21264,,5100817,CHEMBL1640231,Antibacterial activity against Vibrio fluvialis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL614602,Vibrio fluvialis,Vibrio fluvialis,676.0,,MIC50,ug ml-1,UO_0000274,0.016
21265,,5100823,CHEMBL1640231,Antibacterial activity against Vibrio fluvialis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL614602,Vibrio fluvialis,Vibrio fluvialis,676.0,,MIC,ug ml-1,UO_0000274,0.001
21266,,5100835,CHEMBL1640228,Antibacterial activity against Vibrio alginolyticus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614599,Vibrio alginolyticus,Vibrio alginolyticus,663.0,,MIC90,ug ml-1,UO_0000274,0.06
21267,,5100841,CHEMBL1640228,Antibacterial activity against Vibrio alginolyticus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL614599,Vibrio alginolyticus,Vibrio alginolyticus,663.0,,MIC50,ug ml-1,UO_0000274,0.016
21268,,5100847,CHEMBL1640228,Antibacterial activity against Vibrio alginolyticus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL614599,Vibrio alginolyticus,Vibrio alginolyticus,663.0,,MIC,ug ml-1,UO_0000274,0.001
21269,,5100859,CHEMBL1640225,Antibacterial activity against Vibrio parahaemolyticus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC90,ug ml-1,UO_0000274,0.06
21270,,5100865,CHEMBL1640225,Antibacterial activity against Vibrio parahaemolyticus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC50,ug ml-1,UO_0000274,0.016
21271,,5100871,CHEMBL1640225,Antibacterial activity against Vibrio parahaemolyticus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,0.001
21272,,5100883,CHEMBL1640222,Antibacterial activity against Vibrio cholerae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC90,ug ml-1,UO_0000274,0.06
21273,,5100889,CHEMBL1640222,Antibacterial activity against Vibrio cholerae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC50,ug ml-1,UO_0000274,0.016
21274,,5100895,CHEMBL1640222,Antibacterial activity against Vibrio cholerae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,<=,1,1,<=,MIC,ug.mL-1,0.001,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,ug ml-1,UO_0000274,0.001
21275,,5100900,CHEMBL1640221,Antibacterial activity against Plesiomonas shigelloides assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,Activity,%,UO_0000187,0.0
21276,,5100905,CHEMBL1640220,Antibacterial activity against Plesiomonas shigelloides assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,Activity,%,UO_0000187,100.0
21277,,5100911,CHEMBL1640219,Antibacterial activity against Plesiomonas shigelloides by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.004,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,MIC50,ug ml-1,UO_0000274,0.004
21278,,5100917,CHEMBL1640219,Antibacterial activity against Plesiomonas shigelloides by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,MIC,ug ml-1,UO_0000274,0.002
21279,,5100922,CHEMBL1640218,Antibacterial activity against Aeromonas veronii assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,2.0
21280,,5100927,CHEMBL1639490,Antibacterial activity against Aeromonas veronii assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,98.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,98.0
21281,,5100933,CHEMBL1639489,Antibacterial activity against Aeromonas veronii by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.06
21282,,5100939,CHEMBL1639489,Antibacterial activity against Aeromonas veronii by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.004
21283,,5100945,CHEMBL1639488,Antibacterial activity against Aeromonas sobria assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,2.0,CHEMBL614400,Aeromonas sobria,Aeromonas sobria,646.0,,Activity,%,UO_0000187,2.0
21284,,5100950,CHEMBL1639487,Antibacterial activity against Aeromonas sobria assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,98.0,CHEMBL614400,Aeromonas sobria,Aeromonas sobria,646.0,,Activity,%,UO_0000187,98.0
21285,,5100956,CHEMBL1639328,Antibacterial activity against Aeromonas sobria by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614400,Aeromonas sobria,Aeromonas sobria,646.0,,MIC90,ug ml-1,UO_0000274,0.06
21286,,5100962,CHEMBL1639328,Antibacterial activity against Aeromonas sobria by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.004,CHEMBL614400,Aeromonas sobria,Aeromonas sobria,646.0,,MIC50,ug ml-1,UO_0000274,0.004
21287,,5100968,CHEMBL1639327,Antibacterial activity against Aeromonas caviae assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,2.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,Activity,%,UO_0000187,2.0
21288,,5100973,CHEMBL1639326,Antibacterial activity against Aeromonas caviae assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,98.0,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,Activity,%,UO_0000187,98.0
21289,,5100979,CHEMBL1639325,Antibacterial activity against Aeromonas caviae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,MIC90,ug ml-1,UO_0000274,0.06
21290,,5100985,CHEMBL1639325,Antibacterial activity against Aeromonas caviae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.004,CHEMBL613786,Aeromonas caviae,Aeromonas caviae,648.0,,MIC50,ug ml-1,UO_0000274,0.004
21291,,5100991,CHEMBL1639324,Antibacterial activity against Aeromonas hydrophila assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,2.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,Activity,%,UO_0000187,2.0
21292,,5100996,CHEMBL1639323,Antibacterial activity against Aeromonas hydrophila assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,98.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,Activity,%,UO_0000187,98.0
21293,,5101002,CHEMBL1639322,Antibacterial activity against Aeromonas hydrophila by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,MIC90,ug ml-1,UO_0000274,0.06
21294,,5101008,CHEMBL1639322,Antibacterial activity against Aeromonas hydrophila by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.004,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,MIC50,ug ml-1,UO_0000274,0.004
21295,,5101014,CHEMBL1639321,Antibacterial activity against Yersinia pseudotuberculosis assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,Activity,%,UO_0000187,0.0
21296,,5101019,CHEMBL1639320,Antibacterial activity against Yersinia pseudotuberculosis assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,Activity,%,UO_0000187,100.0
21297,,5101025,CHEMBL1639319,Antibacterial activity against Yersinia pseudotuberculosis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,MIC90,ug ml-1,UO_0000274,0.03
21298,,5101031,CHEMBL1639319,Antibacterial activity against Yersinia pseudotuberculosis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,MIC50,ug ml-1,UO_0000274,0.016
21299,,5101036,CHEMBL1639319,Antibacterial activity against Yersinia pseudotuberculosis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,MIC,ug ml-1,UO_0000274,0.008
21300,,5101041,CHEMBL1639318,Antibacterial activity against Yersinia enterocolitica assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,Activity,%,UO_0000187,0.0
21301,,5101046,CHEMBL1639317,Antibacterial activity against Yersinia enterocolitica assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,Activity,%,UO_0000187,100.0
21302,,5101052,CHEMBL1639316,Antibacterial activity against Yersinia enterocolitica by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC90,ug ml-1,UO_0000274,0.03
21303,,5101058,CHEMBL1639316,Antibacterial activity against Yersinia enterocolitica by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.016,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC50,ug ml-1,UO_0000274,0.016
21304,,5101063,CHEMBL1639316,Antibacterial activity against Yersinia enterocolitica by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614398,Yersinia enterocolitica,Yersinia enterocolitica,630.0,,MIC,ug ml-1,UO_0000274,0.008
21305,,5101068,CHEMBL1639315,Antibacterial activity against Shigella dysenteriae assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,Activity,%,UO_0000187,0.0
21306,,5101073,CHEMBL1639314,Antibacterial activity against Shigella dysenteriae assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,Activity,%,UO_0000187,100.0
21307,,5101079,CHEMBL1639313,Antibacterial activity against Shigella dysenteriae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.016,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC90,ug ml-1,UO_0000274,0.016
21308,,5101085,CHEMBL1639313,Antibacterial activity against Shigella dysenteriae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC50,ug ml-1,UO_0000274,0.008
21309,,5101089,CHEMBL1639313,Antibacterial activity against Shigella dysenteriae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,MIC,ug ml-1,UO_0000274,0.004
21310,,5101094,CHEMBL1639312,Antibacterial activity against Shigella boydii assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,Activity,%,UO_0000187,0.0
21311,,5101099,CHEMBL1639311,Antibacterial activity against Shigella boydii assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,Activity,%,UO_0000187,100.0
21312,,5101105,CHEMBL1639310,Antibacterial activity against Shigella boydii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.016,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,MIC90,ug ml-1,UO_0000274,0.016
21313,,5101111,CHEMBL1639310,Antibacterial activity against Shigella boydii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,MIC50,ug ml-1,UO_0000274,0.008
21314,,5101115,CHEMBL1639310,Antibacterial activity against Shigella boydii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,MIC,ug ml-1,UO_0000274,0.004
21315,,5101120,CHEMBL1639309,Antibacterial activity against Shigella flexneri assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,Activity,%,UO_0000187,0.0
21316,,5101513,CHEMBL1636610,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 34404 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629498,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316634,=,1,1,=,MIC,ug.mL-1,7.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,7.8
21317,,5101536,CHEMBL1636611,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 700787 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629498,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316634,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,62.5
21318,,5101559,CHEMBL1636612,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 700698 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629498,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316634,=,1,1,=,MIC,ug.mL-1,7.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,7.8
21319,,5101582,CHEMBL1636613,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-39 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629498,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316634,=,1,1,=,MIC,ug.mL-1,7.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,7.8
21320,,5101605,CHEMBL1636614,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1680 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629498,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316634,=,1,1,=,MIC,ug.mL-1,7.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,7.8
21321,,5102224,CHEMBL1639308,Antibacterial activity against Shigella flexneri assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,Activity,%,UO_0000187,100.0
21322,,5102230,CHEMBL1639307,Antibacterial activity against Shigella flexneri by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.016,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC90,ug ml-1,UO_0000274,0.016
21323,,5102236,CHEMBL1639307,Antibacterial activity against Shigella flexneri by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC50,ug ml-1,UO_0000274,0.008
21324,,5102240,CHEMBL1639307,Antibacterial activity against Shigella flexneri by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,MIC,ug ml-1,UO_0000274,0.004
21325,,5102245,CHEMBL1639306,Antibacterial activity against Shigella sonnei assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,Activity,%,UO_0000187,0.0
21326,,5102250,CHEMBL1639305,Antibacterial activity against Shigella sonnei assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,Activity,%,UO_0000187,100.0
21327,,5102256,CHEMBL1639304,Antibacterial activity against Shigella sonnei by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.016,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC90,ug ml-1,UO_0000274,0.016
21328,,5102262,CHEMBL1639304,Antibacterial activity against Shigella sonnei by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC50,ug ml-1,UO_0000274,0.008
21329,,5102267,CHEMBL1639304,Antibacterial activity against Shigella sonnei by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,MIC,ug ml-1,UO_0000274,0.004
21330,,5102272,CHEMBL1639303,Antibacterial activity against Salmonella enterica serovar Heidelberg assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
21331,,5102277,CHEMBL1639302,Antibacterial activity against Salmonella enterica serovar Heidelberg assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
21332,,5102283,CHEMBL1639301,Antibacterial activity against Salmonella enterica serovar Heidelberg by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
21333,,5102289,CHEMBL1639301,Antibacterial activity against Salmonella enterica serovar Heidelberg by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.008
21334,,5102292,CHEMBL1639301,Antibacterial activity against Salmonella enterica serovar Heidelberg by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.004
21335,,5102297,CHEMBL1639300,Antibacterial activity against Salmonella enterica serovar Virchow assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
21336,,5102302,CHEMBL1639299,Antibacterial activity against Salmonella enterica serovar Virchow assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
21337,,5102308,CHEMBL1639298,Antibacterial activity against Salmonella enterica serovar Virchow by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
21338,,5102314,CHEMBL1639298,Antibacterial activity against Salmonella enterica serovar Virchow by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.008
21339,,5102317,CHEMBL1639298,Antibacterial activity against Salmonella enterica serovar Virchow by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.004
21340,,5102322,CHEMBL1639297,Antibacterial activity against Salmonella enterica serovar Newport assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
21341,,5102327,CHEMBL1639296,Antibacterial activity against Salmonella enterica serovar Newport assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
21342,,5102333,CHEMBL1639295,Antibacterial activity against Salmonella enterica serovar Newport by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
21343,,5102339,CHEMBL1639295,Antibacterial activity against Salmonella enterica serovar Newport by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.008
21344,,5102342,CHEMBL1639295,Antibacterial activity against Salmonella enterica serovar Newport by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.004
21345,,5102347,CHEMBL1639294,Antibacterial activity against Salmonella enterica serovar Choleraesuis assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
21346,,5102352,CHEMBL1639293,Antibacterial activity against Salmonella enterica serovar Choleraesuis assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
21347,,5102358,CHEMBL1639292,Antibacterial activity against Salmonella enterica serovar Choleraesuis by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
21348,,5102364,CHEMBL1639292,Antibacterial activity against Salmonella enterica serovar Choleraesuis by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.008
21349,,5102367,CHEMBL1639292,Antibacterial activity against Salmonella enterica serovar Choleraesuis by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.004
21350,,5102372,CHEMBL1639291,Antibacterial activity against Salmonella enterica serovar Paratyphi assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,Activity,%,UO_0000187,0.0
21351,,5102377,CHEMBL1639290,Antibacterial activity against Salmonella enterica serovar Paratyphi assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,Activity,%,UO_0000187,100.0
21352,,5102383,CHEMBL1639289,Antibacterial activity against Salmonella enterica serovar Paratyphi by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC90,ug ml-1,UO_0000274,0.12
21353,,5102389,CHEMBL1639289,Antibacterial activity against Salmonella enterica serovar Paratyphi by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC50,ug ml-1,UO_0000274,0.008
21354,,5102392,CHEMBL1639289,Antibacterial activity against Salmonella enterica serovar Paratyphi by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.004
21355,,5102397,CHEMBL1639288,Antibacterial activity against Salmonella enterica serovar Typhi assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,Activity,%,UO_0000187,0.0
21356,,5102402,CHEMBL1639287,Antibacterial activity against Salmonella enterica serovar Typhi assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,Activity,%,UO_0000187,100.0
21357,,5102408,CHEMBL1639286,Antibacterial activity against Salmonella enterica serovar Typhi by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC90,ug ml-1,UO_0000274,0.12
21358,,5102414,CHEMBL1639286,Antibacterial activity against Salmonella enterica serovar Typhi by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC50,ug ml-1,UO_0000274,0.008
21359,,5102417,CHEMBL1639286,Antibacterial activity against Salmonella enterica serovar Typhi by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.004
21360,,5102422,CHEMBL1639285,Antibacterial activity against Salmonella enterica serovar Enteritidis assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,Activity,%,UO_0000187,0.0
21361,,5102427,CHEMBL1639284,Antibacterial activity against Salmonella enterica serovar Enteritidis assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,Activity,%,UO_0000187,100.0
21362,,5102433,CHEMBL1639283,Antibacterial activity against Salmonella enterica serovar Enteritidis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC90,ug ml-1,UO_0000274,0.12
21363,,5102439,CHEMBL1639283,Antibacterial activity against Salmonella enterica serovar Enteritidis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC50,ug ml-1,UO_0000274,0.008
21364,,5102442,CHEMBL1639283,Antibacterial activity against Salmonella enterica serovar Enteritidis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC,ug ml-1,UO_0000274,0.004
21365,,5102447,CHEMBL1639282,Antibacterial activity against Salmonella enterica serovar Typhimurium assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,0.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,%,UO_0000187,0.0
21366,,5102452,CHEMBL1639281,Antibacterial activity against Salmonella enterica serovar Typhimurium assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,100.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,Activity,%,UO_0000187,100.0
21367,,5102458,CHEMBL1639280,Antibacterial activity against Salmonella enterica serovar Typhimurium by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC90,ug ml-1,UO_0000274,0.12
21368,,5102464,CHEMBL1639280,Antibacterial activity against Salmonella enterica serovar Typhimurium by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC50,ug ml-1,UO_0000274,0.008
21369,,5102467,CHEMBL1639280,Antibacterial activity against Salmonella enterica serovar Typhimurium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.004
21370,,5102472,CHEMBL1639119,Antibacterial activity against Escherichia coli assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,3.0
21371,,5102477,CHEMBL1639118,Antibacterial activity against Escherichia coli assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313035,=,1,0,=,Activity,%,97.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,97.0
21372,,5102483,CHEMBL1639117,Antibacterial activity against Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC90,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.016
21373,,5102489,CHEMBL1639117,Antibacterial activity against Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629662,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313035,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.008
21374,,5102723,CHEMBL1640058,Antitubercular activity against Mycobacterium tuberculosis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629462,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1313995,=,1,1,=,MIC,nM,9.4,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,10'-3microM,UO_0000065,9.4
21375,,5103929,CHEMBL1638805,Antibacterial activity against beta-lactamase CTX-M ESBL-producing Enterobacteriaceae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629664,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313045,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC50,ug ml-1,UO_0000274,32.0
21376,,5103930,CHEMBL1638805,Antibacterial activity against beta-lactamase CTX-M ESBL-producing Enterobacteriaceae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629664,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313045,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC90,ug ml-1,UO_0000274,32.0
21377,,5103931,CHEMBL1638809,Antibacterial activity against beta-lactamase CTX-M ESBL-producing Enterobacteriaceae assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629664,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313045,=,1,0,=,Activity,%,4.3,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,Activity,%,UO_0000187,4.3
21378,,5103952,CHEMBL1638817,Antibacterial activity against beta-lactamase SHV or TEM ESBL-producing Enterobacteriaceae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629664,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313045,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC50,ug ml-1,UO_0000274,32.0
21379,,5103953,CHEMBL1638817,Antibacterial activity against beta-lactamase SHV or TEM ESBL-producing Enterobacteriaceae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629664,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313045,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC90,ug ml-1,UO_0000274,32.0
21380,,5103954,CHEMBL1638989,Antibacterial activity against beta-lactamase SHV or TEM ESBL-producing Enterobacteriaceae assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629664,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313045,=,1,0,=,Activity,%,36.4,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,Activity,%,UO_0000187,36.4
21381,,5105305,CHEMBL1638992,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21382,,5105306,CHEMBL1638993,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21383,,5105307,CHEMBL1638994,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21384,,5105308,CHEMBL1638995,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21385,,5105309,CHEMBL1638996,"Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21386,,5105310,CHEMBL1639733,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21387,,5105311,CHEMBL1639734,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21388,,5105312,CHEMBL1639735,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21389,,5105313,CHEMBL1639736,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21390,,5105314,CHEMBL1639737,"Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 48 hrs by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313072,>,1,1,>,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,32.0
21391,,5105335,CHEMBL1639933,Antimicrobial activity against Neisseria gonorrhoeae WHO. P by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.016
21392,,5105336,CHEMBL1639934,Antimicrobial activity against Neisseria gonorrhoeae WHO. O by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.016
21393,,5105337,CHEMBL1639932,Antimicrobial activity against Neisseria gonorrhoeae WHO. C by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.016
21394,,5105338,CHEMBL1639931,Antimicrobial activity against Neisseria gonorrhoeae 07 QA 02 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.023
21395,,5105339,CHEMBL1639930,Antimicrobial activity against Neisseria gonorrhoeae 93G0065 harboring gyrA D95N mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.125
21396,,5105340,CHEMBL1639929,Antimicrobial activity against Neisseria gonorrhoeae 97G0319 harboring gyrA D95G mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.125
21397,,5105341,CHEMBL1639928,Antimicrobial activity against Neisseria gonorrhoeae 91G0622 harboring gyrA D95N mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.125
21398,,5105342,CHEMBL1639927,Antimicrobial activity against Neisseria gonorrhoeae WHO. G harboring gyrA S91F mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.25
21399,,5105343,CHEMBL1639926,Antimicrobial activity against Neisseria gonorrhoeae 98G0959 harboring gyrA D95N mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.25
21400,,5105344,CHEMBL1639925,Antimicrobial activity against Neisseria gonorrhoeae 07 QA 06 harboring gyrA S91F mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.38
21401,,5105345,CHEMBL1639924,Antimicrobial activity against Neisseria gonorrhoeae 91G0316 harboring gyrA S91F mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.5
21402,,5105346,CHEMBL1639935,Antimicrobial activity against Neisseria gonorrhoeae 92G0551 harboring gyrA S91Y mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.5
21403,,5105347,CHEMBL1639923,Antimicrobial activity against Neisseria gonorrhoeae 98G0798 harboring gyrA S91F mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,1.0
21404,,5105348,CHEMBL1639922,Antimicrobial activity against Neisseria gonorrhoeae 96G0142 harboring gyrA S91Y and parC E91Q mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,1.0
21405,,5105349,CHEMBL1639921,"Antimicrobial activity against Neisseria gonorrhoeae 97G0398 harboring gyrA S91F, D95G and parC S88P mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,2.0
21406,,5105350,CHEMBL1639920,"Antimicrobial activity against Neisseria gonorrhoeae 97G0109 harboring gyrA S91F, D95G and parC D86N mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,2.0
21407,,5105351,CHEMBL1639919,Antimicrobial activity against Neisseria gonorrhoeae WHO. M harboring gyrA S91F and D95G mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,2.0
21408,,5105352,CHEMBL1639918,"Antimicrobial activity against Neisseria gonorrhoeae 98G0867 harboring gyrA S91F, D95G and parC S87R mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,8.0
21409,,5105353,CHEMBL1639917,"Antimicrobial activity against Neisseria gonorrhoeae 98G0872 harboring gyrA S91F, D95N and parC E91K mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,8.0
21410,,5105354,CHEMBL1639916,"Antimicrobial activity against Neisseria gonorrhoeae WHO. L harboring gyrA S91F, D95N and parC D86N and S88P mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,16.0
21411,,5105355,CHEMBL1639915,"Antimicrobial activity against Neisseria gonorrhoeae 95G0142 harboring gyrA S91F, D95N and parC S87R mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21412,,5105356,CHEMBL1639913,Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG8 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,0.016
21413,,5105357,CHEMBL1639914,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG16 harboring gyrA S91F, D95A and parC S87R mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,1.5
21414,,5105358,CHEMBL1639912,Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG3 harboring gyrA S91F and D95A mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,3.0
21415,,5105359,CHEMBL1639911,Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG14 harboring gyrA S91F and D95A mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,3.0
21416,,5105360,CHEMBL1639910,"Antimicrobial activity against Neisseria gonorrhoeae isolate 108 175 340 harboring gyrA S91F, D95G and parC E91G mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,4.0
21417,,5105361,CHEMBL1639909,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG13 harboring gyrA S91F, D95A and parC S87N and E91Q mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,12.0
21418,,5105362,CHEMBL1639908,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG9 harboring gyrA S91F, D95A and parC S87N and E91Q mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,16.0
21419,,5105363,CHEMBL1639907,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG1 harboring gyrA S91F, D95Y and parC E91G mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21420,,5105364,CHEMBL1639906,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG2 harboring gyrA S91F, D95Y and parC E91G mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21421,,5105365,CHEMBL1639749,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG5 harboring gyrA S91F, D95A and parC E91G mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21422,,5105366,CHEMBL1639748,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG6 harboring gyrA S91F, D95Y and parC E91G mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21423,,5105367,CHEMBL1639936,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG7 harboring gyrA S91F, D95G and parC S87N and E91Q mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21424,,5105368,CHEMBL1639937,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG10 harboring gyrA S91F, D95G and parC S87R mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21425,,5105369,CHEMBL1639938,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG18 harboring gyrA S91F, D95A and parC S87N mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21426,,5105370,CHEMBL1639939,"Antimicrobial activity against Neisseria gonorrhoeae isolate IPC-NG19 harboring gyrA S91F, D95A and parC S87N mutant gene by Etest",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629666,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313928,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,MIC,ug ml-1,UO_0000274,32.0
21427,,5105388,CHEMBL1639036,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,98.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,98.3
21428,,5105392,CHEMBL1639941,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,83.7,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,83.7
21429,,5105396,CHEMBL1639035,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,96.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,96.3
21430,,5105400,CHEMBL1641025,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,33.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,33.6
21431,,5105404,CHEMBL1640814,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,0.7,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,0.7
21432,,5105409,CHEMBL1640813,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,8.1,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,8.1
21433,,5105414,CHEMBL1640812,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,3.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,3.7
21434,,5105419,CHEMBL1640811,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis assessed as percent susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1313939,=,1,0,=,Activity,%,62.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,62.2
21435,,5105424,CHEMBL1639950,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
21436,,5105429,CHEMBL1639950,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
21437,,5105434,CHEMBL1639950,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
21438,,5105439,CHEMBL1639949,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.06
21439,,5105444,CHEMBL1639949,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
21440,,5105449,CHEMBL1639949,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
21441,,5105454,CHEMBL1639948,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
21442,,5105459,CHEMBL1639948,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,4.0
21443,,5105464,CHEMBL1639948,Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,4.0
21444,,5105469,CHEMBL1639947,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.06
21445,,5105474,CHEMBL1639947,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,4.0
21446,,5105479,CHEMBL1639947,Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629667,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313939,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
21447,,5107332,CHEMBL1635931,Antibacterial activity against Staphylococcus aureus ATCC 25923 at 100 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,23.0
21448,,5107349,CHEMBL1635932,Antibacterial activity against Staphylococcus aureus ATCC 25923 at 200 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,24.0
21449,,5107366,CHEMBL1635933,Antibacterial activity against Bacillus subtilis ATCC 6633 at 100 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,21.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,21.0
21450,,5107383,CHEMBL1635934,Antibacterial activity against Bacillus subtilis ATCC 6633 at 200 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,22.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,22.0
21451,,5107400,CHEMBL1635935,Antibacterial activity against Escherichia coli ATCC 25922 at 100 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,26.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,26.0
21452,,5107417,CHEMBL1635936,Antibacterial activity against Escherichia coli ATCC 25922 at 200 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,27.0
21453,,5107434,CHEMBL1635937,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 100 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,32.0
21454,,5107451,CHEMBL1635938,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 200 ug/ml after 24 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,1316721,=,1,1,=,IZ,mm,33.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,33.0
21455,,5107468,CHEMBL1635939,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.0
21456,,5107485,CHEMBL1635940,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.0
21457,,5107502,CHEMBL1635941,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.0
21458,,5107519,CHEMBL1635942,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,6.0
21459,,5107536,CHEMBL1635943,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,0,=,MBC,ug ml-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,12.5
21460,,5107553,CHEMBL1635944,Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 to 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,0,=,MBC,ug ml-1,12.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,12.5
21461,,5108199,CHEMBL1632916,Antimicrobial activity against Escherichia coli isolate 16 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
21462,,5108200,CHEMBL1632917,Antimicrobial activity against Escherichia coli isolate 32 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21463,,5108201,CHEMBL1632918,Antimicrobial activity against Escherichia coli isolate 86 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21464,,5108202,CHEMBL1632919,Antimicrobial activity against Escherichia coli isolate 36 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21465,,5108203,CHEMBL1632920,Antimicrobial activity against Escherichia coli isolate 100 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
21466,,5108204,CHEMBL1632921,Antimicrobial activity against Escherichia coli isolate Z1 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
21467,,5108205,CHEMBL1632922,Antimicrobial activity against Escherichia coli isolate 49 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
21468,,5108206,CHEMBL1632923,Antimicrobial activity against Escherichia coli ATCC 25922 harboring bla CTX-M-3a gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629672,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313967,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
21469,,5108713,CHEMBL1635945,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,0,=,MBC,ug ml-1,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,12.5
21470,,5108730,CHEMBL1635946,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629517,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316721,=,1,0,=,MBC,ug ml-1,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,12.5
21471,,5113070,CHEMBL1639400,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629481,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314404,=,1,1,=,MIC,ug.mL-1,4.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.7
21472,,5116992,CHEMBL1636261,Antimicrobial activity against Citrobacter freundii obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,72.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,72.0
21473,,5117024,CHEMBL1638678,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21474,,5117029,CHEMBL1632725,Antimicrobial activity against Staphylococcus aureus ATCC 11632 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
21475,,5117066,CHEMBL1638676,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.5
21476,,5117067,CHEMBL1632724,Antimicrobial activity against Bacillus subtilis ATCC 11774 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.5
21477,,5117068,CHEMBL1632726,Antimicrobial activity against Streptococcus salivarius ATCC 13419 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC,ug ml-1,UO_0000274,1.5
21478,,5117094,CHEMBL1638672,Antimicrobial activity against Vibrio alginolyticus ATCC 17749 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614599,Vibrio alginolyticus,Vibrio alginolyticus,663.0,,MIC,ug ml-1,UO_0000274,2.0
21479,,5117103,CHEMBL1638670,Antimicrobial activity against Shigella boydii ATCC 9207 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,MIC,ug ml-1,UO_0000274,2.5
21480,,5117104,CHEMBL1632728,Antimicrobial activity against Streptococcus mitis ATCC 6249 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,2.5
21481,,5117129,CHEMBL1638671,Antimicrobial activity against Aeromonas hydrophila ATCC 7966 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL612509,Aeromonas hydrophila,Aeromonas hydrophila,644.0,,MIC,ug ml-1,UO_0000274,3.0
21482,,5117130,CHEMBL1638674,Antimicrobial activity against Proteus vulgaris ATCC 49132 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,3.0
21483,,5117131,CHEMBL1638677,Antimicrobial activity against Salmonella paratyphi A ATCC 9150 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,4.0
21484,,5117132,CHEMBL1632727,Antimicrobial activity against Streptococcus sanguinis ATCC 10556 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC,ug ml-1,UO_0000274,4.0
21485,,5117149,CHEMBL1638675,Antimicrobial activity against Proteus mirabilis ATCC 7002 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,6.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,6.0
21486,,5117150,CHEMBL1638673,Antimicrobial activity against Vibrio parahaemolyticus ATCC 17802 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314828,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,MIC,ug ml-1,UO_0000274,8.0
21487,,5118035,CHEMBL1636264,Antimicrobial activity against Enterobacter aerogenes obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,96.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,%,UO_0000187,96.0
21488,,5118036,CHEMBL1636267,Antimicrobial activity against Enterobacter cloacae obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,85.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,85.0
21489,,5118037,CHEMBL1636270,Antimicrobial activity against Escherichia coli obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,80.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,80.0
21490,,5118038,CHEMBL1636273,Antimicrobial activity against extended-spectrum beta-lactamase-positive Escherichia coli obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,33.0
21491,,5118039,CHEMBL1636276,Antimicrobial activity against extended-spectrum beta-lactamase-negative Escherichia coli obtained from patient with complicated intra-abdominal infection assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,82.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,82.0
21492,,5118040,CHEMBL1636424,Antimicrobial activity against Klebsiella pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,80.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,80.0
21493,,5118041,CHEMBL1636427,Antimicrobial activity against extended-spectrum beta-lactamase-positive Klebsiella pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,19.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,19.0
21494,,5118042,CHEMBL1636430,Antimicrobial activity against extended-spectrum beta-lactamase-negative Klebsiella pneumoniae assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,93.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,93.0
21495,,5118043,CHEMBL1636433,Antimicrobial activity against extended-spectrum beta-lactamase-positive Klebsiella oxytoca assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,96.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,96.0
21496,,5118044,CHEMBL1636436,Antimicrobial activity against extended-spectrum beta-lactamase-positive Proteus mirabilis assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,97.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,97.0
21497,,5118045,CHEMBL1636439,Antimicrobial activity against Pseudomonas aeruginosa assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,72.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,72.0
21498,,5118046,CHEMBL1636442,Antimicrobial activity against Serratia marcescens assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,93.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,93.0
21499,,5118047,CHEMBL1636445,Antimicrobial activity against Pasteurella sp. assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,15.0,CHEMBL614605,Pasteurella sp.,Pasteurella sp.,759.0,,Activity,%,UO_0000187,15.0
21500,,5118048,CHEMBL1636448,Antimicrobial activity against Pseudomonas fluorescens assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,15.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,Activity,%,UO_0000187,15.0
21501,,5118049,CHEMBL1637282,Antimicrobial activity against Stenotrophomonas maltophilia assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,15.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,15.0
21502,,5118050,CHEMBL1637285,Antimicrobial activity against Acinetobacter sp. assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1315377,=,1,0,=,Activity,%,15.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,Activity,%,UO_0000187,15.0
21503,,5140701,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21504,,5140715,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21505,,5140729,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21506,,5140745,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21507,,5140760,CHEMBL1666068,Antimicrobial activity against Streptococcus pneumoniae 1 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21508,,5140775,CHEMBL1666069,Antimicrobial activity against Streptococcus pneumoniae 2 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21509,,5140790,CHEMBL1666070,Antimicrobial activity against Streptococcus pneumoniae 3 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21510,,5140805,CHEMBL1666071,Antimicrobial activity against Streptococcus pneumoniae 4 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
21511,,5140820,CHEMBL1666072,Antimicrobial activity against Streptococcus pneumoniae 5 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21512,,5140835,CHEMBL1666073,Antimicrobial activity against Streptococcus pneumoniae 6 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21513,,5140850,CHEMBL1666074,Antimicrobial activity against Streptococcus pneumoniae 7 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21514,,5140865,CHEMBL1666075,Antimicrobial activity against Streptococcus pneumoniae 8 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21515,,5140880,CHEMBL1666076,Antimicrobial activity against Streptococcus pneumoniae 9 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21516,,5140895,CHEMBL1666077,Antimicrobial activity against Streptococcus pneumoniae 10 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21517,,5140910,CHEMBL1666078,Antimicrobial activity against Streptococcus pneumoniae 11 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21518,,5141654,CHEMBL1656334,Antimicrobial activity against Pseudomonas aeruginosa isolate M136074 expressing IMP-22 beta lactamase gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325826,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
21519,,5141655,CHEMBL1656467,Antimicrobial activity against Pseudomonas aeruginosa isolate 26285 expressing IMP-13 beta lactamase gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325826,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
21520,,5141656,CHEMBL1656468,Antimicrobial activity against Pseudomonas aeruginosa isolate 22843 expressing VIM-2 beta lactamase gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325826,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
21521,,5141657,CHEMBL1656469,Antimicrobial activity against Pseudomonas aeruginosa isolate 27135 expressing VIM-2 beta lactamase gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325826,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
21522,,5141980,CHEMBL1666079,Antimicrobial activity against Streptococcus pneumoniae 12 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21523,,5141996,CHEMBL1666080,Antimicrobial activity against Streptococcus pneumoniae isolate 24 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21524,,5142011,CHEMBL1666081,Antimicrobial activity against Streptococcus pneumoniae isolate 33 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21525,,5142026,CHEMBL1666082,Antimicrobial activity against Streptococcus pneumoniae isolate 37 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21526,,5142041,CHEMBL1666083,Antimicrobial activity against Streptococcus pneumoniae isolate 1055 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21527,,5142059,CHEMBL1666229,Antimicrobial activity against Streptococcus pneumoniae isolate 1394 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21528,,5142074,CHEMBL1666230,Antimicrobial activity against Streptococcus pneumoniae isolate 1397 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21529,,5142089,CHEMBL1666231,Antimicrobial activity against Streptococcus pneumoniae isolate 1424 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21530,,5142104,CHEMBL1666232,Antimicrobial activity against Streptococcus pneumoniae isolate 1564 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21531,,5142119,CHEMBL1666233,Antimicrobial activity against Streptococcus pneumoniae isolate 2617 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21532,,5142134,CHEMBL1666234,Antimicrobial activity against Streptococcus pneumoniae isolate 2686 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21533,,5142149,CHEMBL1666235,Antimicrobial activity against Streptococcus pneumoniae isolate 2688 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21534,,5142164,CHEMBL1666236,Antimicrobial activity against Streptococcus pneumoniae isolate 2874 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21535,,5142179,CHEMBL1666237,Antimicrobial activity against Streptococcus pneumoniae isolate 2880 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21536,,5142194,CHEMBL1666238,Antimicrobial activity against Streptococcus pneumoniae isolate 3260 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21537,,5142209,CHEMBL1666240,Antimicrobial activity against Streptococcus pneumoniae isolate 3275 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21538,,5142224,CHEMBL1666241,Antimicrobial activity against Streptococcus pneumoniae isolate 3282 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21539,,5142239,CHEMBL1666242,Antimicrobial activity against Streptococcus pneumoniae isolate 3346 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21540,,5142254,CHEMBL1666243,Antimicrobial activity against Streptococcus pneumoniae isolate 3374 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21541,,5142269,CHEMBL1666244,Antimicrobial activity against Streptococcus pneumoniae isolate 3412 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21542,,5142284,CHEMBL1666245,Antimicrobial activity against Streptococcus pneumoniae isolate 3455 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21543,,5142299,CHEMBL1666246,Antimicrobial activity against Streptococcus pneumoniae isolate 3458 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21544,,5142314,CHEMBL1666247,Antimicrobial activity against Streptococcus pneumoniae isolate 3481 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21545,,5142329,CHEMBL1666248,Antimicrobial activity against Streptococcus pneumoniae isolate 3587 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21546,,5143397,CHEMBL1666249,Antimicrobial activity against Streptococcus pneumoniae isolate 3681 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21547,,5143412,CHEMBL1666250,Antimicrobial activity against Streptococcus pneumoniae isolate 3791 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21548,,5143427,CHEMBL1666251,Antimicrobial activity against Streptococcus pneumoniae isolate 4747 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21549,,5143442,CHEMBL1666252,Antimicrobial activity against Streptococcus pneumoniae isolate 4755 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21550,,5143470,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
21551,,5143484,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
21552,,5143498,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
21553,,5143512,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,32.0
21554,,5143526,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
21555,,5143540,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,8.0
21556,,5143559,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
21557,,5143573,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
21558,,5143614,CHEMBL1666084,Antimicrobial activity against Streptococcus pneumoniae isolate 1146 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21559,,5143615,CHEMBL1666227,Antimicrobial activity against Streptococcus pneumoniae isolate 1147 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21560,,5143616,CHEMBL1666228,Antimicrobial activity against Streptococcus pneumoniae isolate 1384 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21561,,5143617,CHEMBL1666239,Antimicrobial activity against Streptococcus pneumoniae isolate 3263 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326384,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21562,,5145619,CHEMBL1662758,Antimicrobial activity against compound-susceptible Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649130,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325673,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21563,,5145620,CHEMBL1662760,Antimicrobial activity against compound-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649130,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325673,>=,1,1,>=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
21564,,5145621,CHEMBL1662759,Antimicrobial activity against compound-intermediate Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649130,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325673,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21565,,5145622,CHEMBL1662741,Antimicrobial activity against Streptococcus pneumoniae assessed as resistant isolates broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649130,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1325673,=,1,0,=,Activity,%,1.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.7
21566,Active,5148878,CHEMBL1661666,Bactericidal activity against sodA gene-deficient Escherichia coli K-12 3144 at 0.4 ug/ml,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326013,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
21567,Active,5148879,CHEMBL1661667,Bactericidal activity against sodA gene-deficient Escherichia coli K-12 3144 after 2 hrs,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326013,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
21568,Active,5148880,CHEMBL1661668,Bactericidal activity against sodB gene-deficient Escherichia coli K-12 3145 at 0.4 ug/ml,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326013,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
21569,Active,5148881,CHEMBL1661669,Bactericidal activity against sodB gene-deficient Escherichia coli K-12 3145 after 2 hrs,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326013,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
21570,,5149138,CHEMBL1666469,Antimicrobial activity against compound-resistant Coxiella burnetii Nine-Mile obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21571,,5149139,CHEMBL1666470,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii Nine-Mile obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21572,,5149140,CHEMBL1666471,Antimicrobial activity against compound-susceptible Coxiella burnetii Nine-Mile obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21573,,5149141,CHEMBL1666472,Antimicrobial activity against compound-resistant Coxiella burnetii Q212 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21574,,5149142,CHEMBL1666473,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii Q212 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21575,,5149143,CHEMBL1666474,Antimicrobial activity against compound-susceptible Coxiella burnetii Q212 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,8.0
21576,,5149144,CHEMBL1666475,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP1 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21577,,5149145,CHEMBL1666476,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP1 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21578,,5149146,CHEMBL1666477,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP1 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,8.0
21579,,5149147,CHEMBL1666478,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP2 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21580,,5149148,CHEMBL1666479,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP2 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21581,,5149149,CHEMBL1666480,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP2 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21582,,5149150,CHEMBL1666481,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP3 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21583,,5149151,CHEMBL1666482,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP3 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21584,,5149152,CHEMBL1666483,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP3 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21585,,5149153,CHEMBL1667350,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP4 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21586,,5149154,CHEMBL1667351,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP4 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21587,,5149155,CHEMBL1667352,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP4 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21588,,5149156,CHEMBL1667353,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP5 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21589,,5149157,CHEMBL1667354,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP5 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21590,,5149158,CHEMBL1667355,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP5 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21591,,5149159,CHEMBL1667356,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP6 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21592,,5149160,CHEMBL1667357,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP6 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21593,,5149161,CHEMBL1667358,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP6 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21594,,5149162,CHEMBL1667359,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP7 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21595,,5149163,CHEMBL1667360,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP7 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21596,,5149164,CHEMBL1667361,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP7 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21597,,5149165,CHEMBL1667362,Antimicrobial activity against compound-resistant Coxiella burnetii isolate CP8 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,1.0
21598,,5149166,CHEMBL1667363,Antimicrobial activity against compound-intermediate susceptible Coxiella burnetii isolate CP8 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,2.0
21599,,5149167,CHEMBL1667364,Antimicrobial activity against compound-susceptible Coxiella burnetii isolate CP8 obtained from patient with acute Q fever infected in african green monkey Vero cells after 24 hrs by shell vial assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649456,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326429,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301408,Coxiella burnetii,Coxiella burnetii,777.0,,MIC,ug ml-1,UO_0000274,4.0
21600,,5149229,CHEMBL1667503,Antimicrobial activity against Waddlia chondrophila ATCC VR-1470 infected in Acanthamoeba castellanii amoeba cells,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649457,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326435,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,16.0
21601,,5149230,CHEMBL1667505,Antimicrobial activity against Waddlia chondrophila ATCC VR-1470 infected in Vero cells,F,BAO_0002146,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649457,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326435,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,16.0
21602,,5149231,CHEMBL1667506,Antimicrobial activity against Parachlamydia acanthamoebae infected in Acanthamoeba castellanii amoeba cells,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649457,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326435,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,16.0
21603,,5149232,CHEMBL1667507,Antimicrobial activity against Chlamydia trachomatis infected in Vero cells,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649457,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326435,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,MIC,ug ml-1,UO_0000274,0.5
21604,,5149233,CHEMBL1667508,Antimicrobial activity against Chlamydophila pneumoniae infected in Vero cells,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649457,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326435,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,MIC,ug ml-1,UO_0000274,1.0
21605,,5149234,CHEMBL1667509,Antimicrobial activity against Chlamydophila psittaci infected in Vero cells,F,BAO_0002146,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649457,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326435,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,1.0
21606,,5149283,CHEMBL1667510,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.19
21607,,5149284,CHEMBL1667511,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutY::Gm mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.19
21608,,5149285,CHEMBL1667512,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutT::Gm mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.25
21609,,5149286,CHEMBL1667513,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutM::Gm mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.19
21610,,5149287,CHEMBL1667519,Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of Ceftazidime by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
21611,,5149288,CHEMBL1667520,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of Ceftazidime by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.17,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.17
21612,,5149289,CHEMBL1667521,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of Ceftazidime by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.13
21613,,5149290,CHEMBL1667522,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of Ceftazidime by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.16,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.16
21614,,5149291,CHEMBL1667523,Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of tobramycin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.32,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.32
21615,,5149292,CHEMBL1667524,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of tobramycin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.16,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.16
21616,,5149293,CHEMBL1667525,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of tobramycin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.11,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.11
21617,,5149294,CHEMBL1667526,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of tobramycin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.08,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.08
21618,,5149295,CHEMBL1667527,Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of ciprofloxacin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.75
21619,,5149296,CHEMBL1667528,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of ciprofloxacin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.75
21620,,5149297,CHEMBL1667529,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of ciprofloxacin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.88,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.88
21621,,5149298,CHEMBL1665502,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of ciprofloxacin by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326441,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.75
21622,,5149339,CHEMBL1667514,Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as microbial doubling time,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,1326441,=,1,1,=,TIME,hr,0.4333,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,min,UO_0000032,26.0
21623,,5149344,CHEMBL1667515,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutY::Gm mutant gene assessed as doubling time,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,1326441,=,1,1,=,TIME,hr,0.4283,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,min,UO_0000032,25.7
21624,,5149349,CHEMBL1667516,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutT::Gm mutant gene assessed as doubling time,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,1326441,=,1,1,=,TIME,hr,0.4617,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,min,UO_0000032,27.7
21625,,5149354,CHEMBL1667517,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutM::Gm mutant gene assessed as doubling time,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Hour,1326441,=,1,1,=,TIME,hr,0.455,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,min,UO_0000032,27.3
21626,,5150566,CHEMBL1666821,Antimicrobial activity against Acinetobacter baumannii 3208 expressing multiple-antibiotic resistance gene AbaR5 by Viek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649484,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326712,>=,1,1,>=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
21627,,5150572,CHEMBL1664909,Antimicrobial activity against Enterobacter cloacae clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,29.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,29.0
21628,,5150575,CHEMBL1664908,Antimicrobial activity against Enterobacter cloacae clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.25
21629,,5150578,CHEMBL1664907,Antimicrobial activity against Klebsiella oxytoca clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,57.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,57.0
21630,,5150581,CHEMBL1664906,Antimicrobial activity against Klebsiella oxytoca clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,29.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,29.0
21631,,5150584,CHEMBL1664905,Antimicrobial activity against Klebsiella oxytoca clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.25
21632,,5150587,CHEMBL1664904,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,25.0
21633,,5150590,CHEMBL1664903,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,25.0
21634,,5150593,CHEMBL1664902,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21635,,5150596,CHEMBL1664901,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,20.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,20.0
21636,,5150599,CHEMBL1664900,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,0.0
21637,,5150602,CHEMBL1664899,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21638,,5150605,CHEMBL1664898,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
21639,,5150608,CHEMBL1667541,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
21640,,5150611,CHEMBL1667540,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21641,,5150614,CHEMBL1667539,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
21642,,5150617,CHEMBL1667538,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
21643,,5150620,CHEMBL1667537,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21644,,5150623,CHEMBL1667536,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,88.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,88.0
21645,,5150626,CHEMBL1667535,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,4.0
21646,,5150629,CHEMBL1667534,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,2.0
21647,,5150632,CHEMBL1667534,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.5
21648,,5150635,CHEMBL1667534,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
21649,,5150638,CHEMBL1667533,Antimicrobial activity against Klebsiella oxytoca isolate M2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,4.0
21650,,5150641,CHEMBL1667532,Antimicrobial activity against Klebsiella pneumoniae isolate V2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21651,,5150644,CHEMBL1667531,Antimicrobial activity against Klebsiella pneumoniae isolate C2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
21652,,5150647,CHEMBL1667530,Antimicrobial activity against Klebsiella pneumoniae isolate M2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
21653,,5150650,CHEMBL1666839,Antimicrobial activity against Klebsiella pneumoniae isolate Y2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21654,,5150653,CHEMBL1666838,Antimicrobial activity against Escherichia coli isolate M3 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21655,,5150656,CHEMBL1666837,Antimicrobial activity against Escherichia coli isolate M2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21656,,5150659,CHEMBL1666836,Antimicrobial activity against Escherichia coli isolate Y3 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21657,,5150662,CHEMBL1666824,Antimicrobial activity against Escherichia coli isolate Y2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21658,,5150665,CHEMBL1666825,Antimicrobial activity against Citrobacter freundii isolate V1 harboring qnrB10 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.25
21659,,5150668,CHEMBL1666826,Antimicrobial activity against Klebsiella oxytoca isolate M1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.25
21660,,5150671,CHEMBL1666827,Antimicrobial activity against Enterobacter cloacae isolate V1 harboring qnrB2 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,2.0
21661,,5150674,CHEMBL1666828,Antimicrobial activity against Escherichia hermannii isolate C1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
21662,,5150677,CHEMBL1666829,Antimicrobial activity against Klebsiella pneumoniae isolate V1 harboring qnrB2 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21663,,5150680,CHEMBL1666830,Antimicrobial activity against Klebsiella pneumoniae isolate M1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
21664,,5150683,CHEMBL1666831,Antimicrobial activity against Klebsiella pneumoniae isolate Y1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
21665,,5150686,CHEMBL1666832,Antimicrobial activity against Escherichia coli isolate V1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
21666,,5150689,CHEMBL1666834,Antimicrobial activity against Escherichia coli isolate C1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21667,,5150692,CHEMBL1666833,Antimicrobial activity against Escherichia coli isolate M1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
21668,,5150695,CHEMBL1666835,Antimicrobial activity against Escherichia coli isolate Y1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
21669,,5150697,CHEMBL1664910,Antimicrobial activity against Enterobacter cloacae clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,57.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,57.0
21670,,5150700,CHEMBL1664911,Antimicrobial activity against Escherichia hermannii clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
21671,,5150703,CHEMBL1664912,Antimicrobial activity against Escherichia hermannii clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,29.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,29.0
21672,,5150706,CHEMBL1664913,Antimicrobial activity against Escherichia hermannii clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,57.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,57.0
21673,,5150709,CHEMBL1664914,Antimicrobial activity against Citrobacter freundii clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326714,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.25
21674,,5150712,CHEMBL1664915,Antimicrobial activity against Citrobacter freundii clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,29.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,29.0
21675,,5150715,CHEMBL1664916,Antimicrobial activity against Citrobacter freundii clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326714,=,1,0,=,Activity,%,57.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,57.0
21676,,5150735,CHEMBL1664928,Antimicrobial activity against Extended-spectrum beta-lactamase producing Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649487,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326724,=,1,0,=,Activity,%,79.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,79.0
21677,,5151870,CHEMBL1662381,Antimicrobial activity against Proteus mirabilis 06-489 isolated from infected human urinary tract by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.25
21678,,5151871,CHEMBL1662383,Antimicrobial activity against Escherichia coli J53 transconjugated with Proteus mirabilis pHS10 carrying qnrC gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
21679,,5151872,CHEMBL1662385,Antimicrobial activity against Escherichia coli J53 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
21680,,5152944,CHEMBL1662386,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21681,,5152945,CHEMBL1662387,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATG to ACG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21682,,5152946,CHEMBL1662388,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to ATG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
21683,,5152947,CHEMBL1662389,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TCG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
21684,,5152948,CHEMBL1662390,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TTA substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.003
21685,,5152949,CHEMBL1662391,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to ATG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21686,,5152950,CHEMBL1662392,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to TTA substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21687,,5152951,CHEMBL1662393,Antimicrobial activity against Escherichia coli ATCC 25922 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326061,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
21688,,5153126,CHEMBL1663060,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21689,,5153127,CHEMBL1663061,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S2 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21690,,5153128,CHEMBL1663062,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S3 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21691,,5153129,CHEMBL1663063,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S4 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
21692,,5153130,CHEMBL1663064,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S5 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21693,,5153131,CHEMBL1663065,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S6 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21694,,5153132,CHEMBL1663066,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S7 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
21695,,5153133,CHEMBL1663067,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S8 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21696,,5153134,CHEMBL1663068,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S9 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21697,,5153135,CHEMBL1663069,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S10 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21698,,5153136,CHEMBL1663070,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S11 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21699,,5153137,CHEMBL1663071,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S12 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,<,1,1,<,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
21700,,5153138,CHEMBL1663072,Antimicrobial activity against blaKPC-positive Klebsiella oxytoca S13 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.06
21701,,5153139,CHEMBL1663073,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S14 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21702,,5153140,CHEMBL1663074,Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S15 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649191,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326099,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
21703,,5154461,CHEMBL1655538,Antimicrobial activity against Pseudomonas aeruginosa mutGR1 overexpressing mexXY mutant by twofold macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21704,,5154462,CHEMBL1655537,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by twofold macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21705,,5154626,CHEMBL1655539,Antimicrobial activity against mexXY deficient ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant by twofold macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21706,,5154627,CHEMBL1655540,Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY operon by twofold macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21707,,5154628,CHEMBL1655541,Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY F29S mutant by twofold macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21708,,5154629,CHEMBL1655542,Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY F1018L mutant by twofold macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21709,,5154630,CHEMBL1655543,Antimicrobial activity against Pseudomonas aeruginosa isolate 615S obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
21710,,5154631,CHEMBL1655544,Antimicrobial activity against Pseudomonas aeruginosa isolate 615R obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21711,,5154632,CHEMBL1655545,Antimicrobial activity against Pseudomonas aeruginosa isolate 3020S obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21712,,5154633,CHEMBL1655546,Antimicrobial activity against Pseudomonas aeruginosa isolate 3020R obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21713,,5154634,CHEMBL1655547,Antimicrobial activity against Pseudomonas aeruginosa isolate 2715 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21714,,5154635,CHEMBL1655548,Antimicrobial activity against Pseudomonas aeruginosa isolate 2716 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
21715,,5154636,CHEMBL1655549,Antimicrobial activity against Pseudomonas aeruginosa isolate 2721 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21716,,5154637,CHEMBL1655550,Antimicrobial activity against Pseudomonas aeruginosa isolate 2729 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21717,,5154638,CHEMBL1655551,Antimicrobial activity against Pseudomonas aeruginosa isolate 2804 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
21718,,5154639,CHEMBL1655552,Antimicrobial activity against Pseudomonas aeruginosa isolate 2858 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21719,,5154640,CHEMBL1655553,Antimicrobial activity against Pseudomonas aeruginosa isolate 2933 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21720,,5154641,CHEMBL1655554,Antimicrobial activity against Pseudomonas aeruginosa isolate 2998 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21721,,5154642,CHEMBL1655555,Antimicrobial activity against Pseudomonas aeruginosa isolate 3066 obtained from cystic fibrosis patient by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326134,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
21722,,5154855,CHEMBL1665964,Antimicrobial activity against Klebsiella oxytoca KO279 harboring beta-lactamase OXY-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.38
21723,,5154856,CHEMBL1665965,Antimicrobial activity against Klebsiella oxytoca KO280 harboring beta-lactamase OXY-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.25
21724,,5154857,CHEMBL1665966,Antimicrobial activity against Klebsiella oxytoca KO281 harboring beta-lactamase OXY-1 and CMY-2 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.38
21725,,5154858,CHEMBL1665967,Antimicrobial activity against Klebsiella pneumoniae 101A harboring beta-lactamase CMY-2 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.047
21726,,5154859,CHEMBL1665968,Antimicrobial activity against Klebsiella pneumoniae 278 harboring beta-lactamase OXY-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.38
21727,,5154860,CHEMBL1665969,Antimicrobial activity against Klebsiella pneumoniae 278sp by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.047
21728,,5154861,CHEMBL1665970,Antimicrobial activity against Escherichia coli TF-KO279 harboring beta-lactamase OXY-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21729,,5154862,CHEMBL1665971,Antimicrobial activity against Escherichia coli TF-KO281 harboring beta-lactamase OXY-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21730,,5154863,CHEMBL1665972,Antimicrobial activity against Escherichia coli TF-KP278 harboring beta-lactamase OXY-1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
21731,,5154864,CHEMBL1665973,Antimicrobial activity against Escherichia coli DH5alpha by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649490,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326738,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
21732,,5155810,CHEMBL1655660,Ratio of MIC for Pseudomonas aeruginosa 615S to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21733,,5155811,CHEMBL1655661,Ratio of MIC for Pseudomonas aeruginosa 615R to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21734,,5155812,CHEMBL1655663,Ratio of MIC for Pseudomonas aeruginosa 2715 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21735,,5155813,CHEMBL1655664,Ratio of MIC for Pseudomonas aeruginosa 2716 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21736,,5155814,CHEMBL1655665,Ratio of MIC for Pseudomonas aeruginosa 2721 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21737,,5155815,CHEMBL1655666,Ratio of MIC for Pseudomonas aeruginosa 2729 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21738,,5155816,CHEMBL1655667,Ratio of MIC for Pseudomonas aeruginosa 2804 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21739,,5155817,CHEMBL1655670,Ratio of MIC for Pseudomonas aeruginosa 2998 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21740,,5155818,CHEMBL1655671,Ratio of MIC for Pseudomonas aeruginosa 3066 to MIC for Pseudomonas aeruginosa PAO1,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326134,>=,1,0,>=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
21741,,5155909,CHEMBL1656462,Antimicrobial activity against Ureaplasma urealyticum isolate HPA3 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21742,,5155910,CHEMBL1656463,Antimicrobial activity against Ureaplasma urealyticum isolate HPA6 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21743,,5155911,CHEMBL1656464,Antimicrobial activity against Ureaplasma urealyticum isolate HPA12 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21744,,5155912,CHEMBL1656465,Antimicrobial activity against Ureaplasma urealyticum isolate HPA17 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21745,,5155913,CHEMBL1656466,Antimicrobial activity against Ureaplasma parvum SV1 isolate HPA18 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,8.0
21746,,5155914,CHEMBL1656617,Antimicrobial activity against Ureaplasma urealyticum isolate HPA20 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21747,,5155915,CHEMBL1656618,Antimicrobial activity against Ureaplasma parvum SV6 isolate HPA23 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,<,1,1,<,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,2.0
21748,,5155916,CHEMBL1656619,Antimicrobial activity against Ureaplasma parvum SV14 isolate HPA32 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,<,1,1,<,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,2.0
21749,,5155917,CHEMBL1656620,Antimicrobial activity against Ureaplasma parvum isolate UHWJM after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21750,,5155918,CHEMBL1656621,Antimicrobial activity against Ureaplasma parvum SV1 isolate UHWO10 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21751,,5155919,CHEMBL1656622,Antimicrobial activity against Ureaplasma parvum isolate UHWP2 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21752,,5155920,CHEMBL1656623,Antimicrobial activity against Ureaplasma parvum SV1 isolate UHWQ3 after 48 hrs by modified broth microdilution technique,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326142,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,4.0
21753,,5156158,CHEMBL1657690,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring deltaampD::lox deltaampDh2::lox deltaampDh3::lox after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649427,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326155,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
21754,,5156852,CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325750,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.002
21755,,5156863,CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325750,=,1,1,=,MIC50,ug.mL-1,0.004,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.004
21756,,5156874,CHEMBL1661857,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325750,=,1,1,=,MIC90,ug.mL-1,0.004,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.004
21757,,5156885,CHEMBL1661858,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent susceptible isolates by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1325750,=,1,0,=,Activity,%,100.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,100.0
21758,,5156896,CHEMBL1661859,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent intermediate isolates by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1325750,=,1,0,=,Activity,%,0.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,0.0
21759,,5156907,CHEMBL1662505,Antibacterial activity against Beta-lactamase-negative Neisseria meningitidis assessed as percent resistant isolates by Etest method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649154,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1325750,=,1,0,=,Activity,%,0.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,0.0
21760,,5157178,CHEMBL1657696,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring deltaampD::lox deltaampDh2::lox delta ampDh3::lox after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649427,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326155,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
21761,,5157179,CHEMBL1657693,Antimicrobial activity against nagZ gene-deficient Pseudomonas aeruginosa PAO1 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649427,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326155,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
21762,,5157180,CHEMBL1657699,Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649427,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326155,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
21763,,5157369,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326307,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.015
21764,,5157379,CHEMBL1660791,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326307,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
21765,,5157389,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326307,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.5
21766,,5157399,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326307,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,1.0
21767,,5157414,CHEMBL1660797,Antimicrobial activity against Salmonella enterica serotype concord expressing extended-spectrum beta-lactamase CTX-M-15 by disc diffusion method,F,BAO_0000181,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649432,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326312,=,1,0,=,Activity,ug ml-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,ug ml-1,UO_0000274,0.25
21768,,5158054,CHEMBL1655741,Antimicrobial activity against Lactobacillus in three-stage chemostat gut model assessed as log reduction in bacterial count at 139 mg/liter administered every 12 hrs for 7 days,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,=,1,0,=,FC,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,FC,,,1.0
21769,,5158055,CHEMBL1655742,Antimicrobial activity against Clostridium in three-stage chemostat gut model assessed as log reduction in bacterial count at 139 mg/liter administered every 12 hrs for 7 days,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,=,1,0,=,FC,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,FC,,,1.0
21770,,5158056,CHEMBL1655743,Antimicrobial activity against Enterococcus in three-stage chemostat gut model assessed as log reduction in bacterial count at 139 mg/liter administered every 12 hrs for 7 days,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,=,1,0,=,FC,,1.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,FC,,,1.0
21771,Active,5158057,CHEMBL1655744,Antimicrobial activity against Bifidobacterium in three-stage chemostat gut model assessed as log reduction in bacterial count at 139 mg/liter administered every 12 hrs for 7 days,F,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
21772,Active,5158058,CHEMBL1655745,Antimicrobial activity against Clostridium difficile PCR ribotype 001 in three-stage chemostat gut model assessed as log reduction in bacterial count at 139 mg/liter administered every 12 hrs for 7 days,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
21773,Active,5158069,CHEMBL1656243,Induction of cytotoxin production in Clostridium difficile PCR ribotype 027 in three-stage chemostat gut model at 139 mg/liter administered every 12 hrs for 7 days measured after 5 days,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
21774,Active,5158070,CHEMBL1656244,Induction of cytotoxin production in Clostridium difficile PCR ribotype 001 in three-stage chemostat gut model at 139 mg/liter administered every 12 hrs for 7 days measured after 3 days,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
21775,,5158078,CHEMBL1656245,Drug level in human feces,A,BAO_0000179,BAO_0000221,tissue-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1325343,=,1,0,=,Drug uptake,mg Kg-1,139.0,CHEMBL612558,,ADMET,,,Drug uptake,mg Kg-1,UO_0000308,139.0
21776,,5158081,CHEMBL1656241,Antimicrobial activity against Clostridium difficile PCR ribotype 027 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325343,=,1,1,=,MIC,ug.mL-1,300.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,300.0
21777,,5158082,CHEMBL1656242,Antimicrobial activity against Clostridium difficile PCR ribotype 001 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325343,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,64.0
21778,,5159835,CHEMBL1656281,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Montevideo isolate AM28704 expressing qnrA1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.00025,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.25
21779,,5159836,CHEMBL1656280,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Cubana isolate AM28764 expressing qnrB2 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug/L,UO_0000274,0.5
21780,,5159837,CHEMBL1656279,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Typhimurium isolate AM27125 expressing qnrB5 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug/L,UO_0000274,0.5
21781,,5159838,CHEMBL1656278,Antimicrobial activity against Salmonella enterica serotype Aqua isolate AM26209 expressing qnrB5 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.00025,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug/L,UO_0000274,0.25
21782,,5159839,CHEMBL1656277,Antimicrobial activity against nalidixic acid-resistant Salmonella enterica serotype Kiambu isolate AM27031 expressing qnrB5 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug/L,UO_0000274,0.5
21783,,5159840,CHEMBL1656276,Antimicrobial activity against Salmonella enterica serotype Typhimurium isolate AM29869 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug/L,UO_0000274,0.5
21784,,5159841,CHEMBL1656275,Antimicrobial activity against Salmonella enterica serotype Typhimurium isolate AM29365 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug/L,UO_0000274,0.5
21785,,5159842,CHEMBL1656274,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Typhimurium isolate AM27549 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug/L,UO_0000274,0.5
21786,,5159843,CHEMBL1656273,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Typhimurium isolate AM27315 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug/L,UO_0000274,0.5
21787,,5159844,CHEMBL1656272,Antimicrobial activity against tetracycline- and trimethoprim-sulfamethoxazole-resistant Salmonella enterica serotype Saintpaul isolate AM26790 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.5
21788,,5159845,CHEMBL1656271,Antimicrobial activity against tetracycline-resistant Salmonella enterica serotype Saintpaul isolate AM30594 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.5
21789,,5159846,CHEMBL1656270,Antimicrobial activity against ampicillin- and streptomycin-resistant Salmonella enterica serotype Enteritidis isolate AM25798 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC,ug/L,UO_0000274,0.5
21790,,5159847,CHEMBL1656269,Antimicrobial activity against Salmonella enterica serotype Corvallis isolate AM25927 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.00025,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.25
21791,,5159848,CHEMBL1656268,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Corvallis isolate AM25736 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.00025,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.25
21792,,5159849,CHEMBL1656267,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Typhimurium var. O:5 isolate AM25008 expressing aac(6')-Ib-cr gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug/L,UO_0000274,1.0
21793,,5159850,CHEMBL1656266,Antimicrobial activity against Salmonella enterica serotype telelkebir isolate AM21420 expressing qnrB5 gene by by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug/L,UO_0000274,0.5
21794,,5159851,CHEMBL1656265,Antimicrobial activity against trimethoprim-sulfamethoxazole-resistant Salmonella enterica serotype Montevideo isolate AM19383 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.5
21795,,5159852,CHEMBL1656264,Antimicrobial activity against multidrug-resistant Salmonella enterica serotype Corvallis isolate AM20376 expressing qnrS1 gene by by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649158,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325770,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.5
21796,,5159897,CHEMBL1653746,Antimicrobial activity against azide-resistant Escherichia coli J53,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
21797,,5159898,CHEMBL1653741,Antimicrobial activity against Klebsiella pneumoniae isolate 132 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
21798,,5159899,CHEMBL1653745,Antimicrobial activity against Klebsiella pneumoniae isolate 202 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
21799,,5159900,CHEMBL1653731,Antimicrobial activity against Enterobacter cloacae isolate 37 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
21800,,5159901,CHEMBL1653733,Antimicrobial activity against Enterobacter cloacae isolate 101 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
21801,,5159902,CHEMBL1653735,Antimicrobial activity against Enterobacter cloacae isolate 153 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
21802,,5159903,CHEMBL1653737,Antimicrobial activity against Escherichia coli isolate 17 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
21803,,5159904,CHEMBL1653739,Antimicrobial activity against Escherichia coli isolate 48 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
21804,,5159915,CHEMBL1653740,Antimicrobial activity against Klebsiella pneumoniae isolate 132 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
21805,,5159931,CHEMBL1653743,Antimicrobial activity against Klebsiella pneumoniae isolate 135 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
21806,,5159939,CHEMBL1653730,Antimicrobial activity against Enterobacter cloacae isolate 37 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,4.0
21807,,5159942,CHEMBL1653732,Antimicrobial activity against Enterobacter cloacae isolate 101 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,8.0
21808,,5159943,CHEMBL1653734,Antimicrobial activity against Enterobacter cloacae isolate 153 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,8.0
21809,,5159979,CHEMBL1653736,Antimicrobial activity against Escherichia coli isolate 17 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21810,,5159980,CHEMBL1653738,Antimicrobial activity against Escherichia coli isolate 48 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
21811,,5159981,CHEMBL1653742,Antimicrobial activity against Klebsiella pneumoniae isolate 135 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
21812,,5159982,CHEMBL1653744,Antimicrobial activity against Klebsiella pneumoniae isolate 202 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326336,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
21813,,5160003,CHEMBL1653747,Ratio of MIC for Enterobacter cloacae isolate 37 transconjugant to MIC for azide-resistant Escherichia coli J53,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL612545,,Unchecked,,,FC,,,2.0
21814,,5160004,CHEMBL1653748,Ratio of MIC for Enterobacter cloacae isolate 101 transconjugant to MIC for azide-resistant Escherichia coli J54,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL612545,,Unchecked,,,FC,,,2.0
21815,,5160005,CHEMBL1653749,Ratio of MIC for Enterobacter cloacae isolate 153 transconjugant to MIC for azide-resistant Escherichia coli J55,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL612545,,Unchecked,,,FC,,,2.0
21816,,5160006,CHEMBL1653750,Ratio of MIC for Escherichia coli isolate 17 transconjugant to MIC for azide-resistant Escherichia coli J56,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
21817,,5160007,CHEMBL1653751,Ratio of MIC for Escherichia coli isolate 48 transconjugant to MIC for azide-resistant Escherichia coli J57,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,FC,,,2.0
21818,,5160008,CHEMBL1653752,Ratio of MIC for Klebsiella pneumoniae isolate 132 transconjugant to MIC for azide-resistant Escherichia coli J58,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL612545,,Unchecked,,,FC,,,2.0
21819,,5160009,CHEMBL1653753,Ratio of MIC for Klebsiella pneumoniae isolate 135 transconjugant to MIC for azide-resistant Escherichia coli J59,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL612545,,Unchecked,,,FC,,,2.0
21820,,5160010,CHEMBL1653754,Ratio of MIC for Klebsiella pneumoniae isolate 202 transconjugant to MIC for azide-resistant Escherichia coli J60,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1326336,=,1,0,=,FC,,2.0,CHEMBL612545,,Unchecked,,,FC,,,2.0
21821,,5160060,CHEMBL1653134,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,16.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,16.3
21822,,5160069,CHEMBL1653137,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,5.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.9
21823,,5160217,CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
21824,,5160227,CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
21825,,5161311,CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
21826,,5161320,CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
21827,,5161330,CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
21828,,5161340,CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,4.0
21829,,5161367,CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
21830,,5161376,CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
21831,,5161386,CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
21832,,5161396,CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
21833,,5161423,CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
21834,,5161432,CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326352,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
21835,,5161446,CHEMBL1653129,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,83.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,83.1
21836,,5161455,CHEMBL1653127,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,92.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.0
21837,,5161500,CHEMBL1653002,Antibacterial activity against Enterococcus faecalis assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,64.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,64.8
21838,,5161510,CHEMBL1652999,Antibacterial activity against Enterococcus faecalis assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,34.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,34.2
21839,,5161520,CHEMBL1653000,Antibacterial activity against Enterococcus faecium assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,6.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,6.9
21840,,5161530,CHEMBL1652997,Antibacterial activity against Enterococcus faecium assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1326352,=,1,0,=,Activity,%,86.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,86.5
21841,,5162732,CHEMBL1665066,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21842,,5162733,CHEMBL1665067,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
21843,,5162734,CHEMBL1665784,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21844,,5162735,CHEMBL1665785,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
21845,,5162736,CHEMBL1665786,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21846,,5162737,CHEMBL1665787,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
21847,,5162738,CHEMBL1665788,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
21848,,5162739,CHEMBL1665789,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
21849,,5162780,CHEMBL1665931,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,8.0
21850,,5162781,CHEMBL1665932,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,8.0
21851,,5162782,CHEMBL1665933,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,128.0
21852,,5162783,CHEMBL1665934,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,128.0
21853,,5162784,CHEMBL1665935,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,64.0
21854,,5162785,CHEMBL1665936,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,64.0
21855,,5162786,CHEMBL1665937,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,256.0
21856,,5162787,CHEMBL1665938,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327007,=,1,0,=,Activity,ug ml-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,256.0
21857,,5163004,CHEMBL1665120,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327029,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.003
21858,,5163011,CHEMBL1665121,Antibacterial activity against quinolone-resistant Escherichia coli TOP10-3963 transformant harboring qnrS1 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327029,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
21859,,5163018,CHEMBL1665119,Antibacterial activity against Escherichia coli 3963 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327029,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
21860,,5163718,CHEMBL1654045,Antibacterial activity against quinolone-susceptible Bordetella pertussis CCUG 30837 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.032
21861,,5163719,CHEMBL1654046,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP101 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
21862,,5163720,CHEMBL1654047,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP106 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
21863,,5163721,CHEMBL1654048,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP109 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
21864,,5163722,CHEMBL1654049,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP111 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
21865,,5163723,CHEMBL1654050,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP112 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
21866,,5163724,CHEMBL1654051,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP113 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
21867,,5163725,CHEMBL1654052,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP115 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
21868,,5163726,CHEMBL1654053,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP128 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
21869,,5163727,CHEMBL1654054,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP58 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.125
21870,,5163728,CHEMBL1654055,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP99 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.125
21871,,5163729,CHEMBL1654056,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP117 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.125
21872,,5163730,CHEMBL1654057,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP118 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.125
21873,,5163731,CHEMBL1654058,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP121 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.125
21874,,5163732,CHEMBL1654059,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP122 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326827,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.125
21875,,5164066,CHEMBL1655176,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14805 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
21876,,5164067,CHEMBL1655177,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14812 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21877,,5164068,CHEMBL1655178,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21878,,5164069,CHEMBL1655179,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16830 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21879,,5164070,CHEMBL1655180,Antimicrobial activity against Pseudomonas aeruginosa isolate OC17349 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
21880,,5164071,CHEMBL1655181,Antimicrobial activity against Pseudomonas aeruginosa isolate OC17355 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
21881,,5164072,CHEMBL1655182,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14552 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.12
21882,,5164073,CHEMBL1655183,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14551 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21883,,5164140,CHEMBL1655184,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21884,,5164141,CHEMBL1655185,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring plasmid MexXY expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21885,,5164142,CHEMBL1655186,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring plasmid MexZ expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.12
21886,,5164143,CHEMBL1655187,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21887,,5164144,CHEMBL1655188,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 harboring plasmid MexXY expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21888,,5164145,CHEMBL1655189,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 harboring plasmid MexZ expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.12
21889,,5164146,CHEMBL1655190,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16830 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21890,,5164147,CHEMBL1655191,Antimicrobial activity against Pseudomonas aeruginosa isolate OC16830 harboring plasmid MexZ expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.12
21891,,5164148,CHEMBL1655192,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14812 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21892,,5164149,CHEMBL1655193,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14812 harboring plasmid MexZ expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21893,,5164150,CHEMBL1655194,Antimicrobial activity against Pseudomonas aeruginosa isolate OC17355 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
21894,,5164151,CHEMBL1655195,Antimicrobial activity against Pseudomonas aeruginosa isolate OC17355 harboring plasmid MexZ expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21895,,5164152,CHEMBL1655196,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14551 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21896,,5164153,CHEMBL1655197,Antimicrobial activity against Pseudomonas aeruginosa isolate OC14551 harboring plasmid MexZ expressing mexXY gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649517,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326982,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
21897,,5164470,CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323847,<=,1,1,<=,MIC50,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.008
21898,,5164481,CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323847,<=,1,1,<=,MIC90,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.008
21899,,5164492,CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323847,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.008
21900,,5164499,CHEMBL1658622,Antimicrobial activity against Neisseria meningitidis assessed as susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1323847,=,1,0,=,Activity,%,97.1,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,97.1
21901,,5164500,CHEMBL1658623,Antimicrobial activity against Neisseria meningitidis assessed as resistant isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1323847,=,1,0,=,Activity,%,1.9,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,1.9
21902,,5164540,CHEMBL1658624,Antimicrobial activity against Neisseria gonorrhoeae assessed as susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1323854,=,1,0,=,Activity,%,51.4,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,Activity,%,UO_0000187,51.4
21903,,5164541,CHEMBL1658626,Antimicrobial activity against Neisseria gonorrhoeae assessed as resistant isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1323854,=,1,0,=,Activity,%,20.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,Activity,%,UO_0000187,20.0
21904,,5164542,CHEMBL1658625,Antimicrobial activity against Neisseria gonorrhoeae assessed as susceptible isolates by EUCAST method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1323854,=,1,0,=,Activity,%,51.4,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,Activity,%,UO_0000187,51.4
21905,,5164543,CHEMBL1658627,Antimicrobial activity against Neisseria gonorrhoeae assessed as resistant isolates by EUCAST method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1323854,=,1,0,=,Activity,%,48.6,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,Activity,%,UO_0000187,48.6
21906,,5166186,CHEMBL1666959,Antimicrobial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,71.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,71.0
21907,,5166187,CHEMBL1666956,Antimicrobial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,75.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,%,UO_0000187,75.0
21908,,5166188,CHEMBL1666963,Antimicrobial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,77.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,77.0
21909,,5166189,CHEMBL1666966,Antimicrobial activity against extended spectrum beta-lactamase-expressing Escherichia coli assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,17.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,17.0
21910,,5166190,CHEMBL1666969,Antimicrobial activity against extended spectrum beta-lactamase-deficient Escherichia coli assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,70.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,70.0
21911,,5166191,CHEMBL1666972,Antimicrobial activity against extended spectrum beta-lactamase-expressing Klebsiella oxytoca assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,27.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,27.0
21912,,5166192,CHEMBL1666975,Antimicrobial activity against extended spectrum beta-lactamase-deficient Klebsiella oxytoca assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,93.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,93.0
21913,,5166193,CHEMBL1666965,Antimicrobial activity against extended spectrum beta-lactamase-expressing Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,27.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,27.0
21914,,5166194,CHEMBL1666980,Antimicrobial activity against extended spectrum beta-lactamase-deficient Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,93.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,93.0
21915,,5166195,CHEMBL1666983,Antimicrobial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,69.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,69.0
21916,,5166196,CHEMBL1666986,Antimicrobial activity against Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327184,=,1,0,=,Activity,%,71.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,71.0
21917,,5166288,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
21918,,5166296,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
21919,,5166305,CHEMBL1667173,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,94.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,94.7
21920,,5166312,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
21921,,5166320,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,ug ml-1,UO_0000274,1.0
21922,,5166327,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,ug ml-1,UO_0000274,1.0
21923,Not Active,5166334,CHEMBL1667172,Antibacterial activity against Listeria monocytogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1327195,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
21924,,5166341,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,0.25
21925,,5166348,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,128.0
21926,,5166355,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,64.0
21927,,5166362,CHEMBL1667171,Antibacterial activity against vancomycin- resistant Enterococcus faecium assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,18.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,18.2
21928,,5166369,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
21929,,5166376,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,64.0
21930,,5166383,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
21931,,5166390,CHEMBL1667170,Antibacterial activity against vancomycin- resistant Enterococcus faecalis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,58.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,58.5
21932,,5166397,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.12
21933,,5166403,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
21934,,5166410,CHEMBL1667174,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,9.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,9.1
21935,,5166419,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
21936,,5166427,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
21937,,5166435,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
21938,,5166442,CHEMBL1667175,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
21939,,5166451,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.12
21940,Not Active,5166459,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1327195,,1,0,,MIC90,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,,,
21941,,5166467,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
21942,,5166475,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.06
21943,,5166483,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.06
21944,,5166491,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC,ug ml-1,UO_0000274,0.06
21945,,5166499,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.06
21946,,5166507,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC,ug ml-1,UO_0000274,0.06
21947,,5167001,CHEMBL1654343,Antibacterial activity against Pseudomonas aeruginosa PAO1 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322913,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21948,,5167010,CHEMBL1654344,Antibacterial activity against Pseudomonas aeruginosa NY214 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322913,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
21949,,5167019,CHEMBL1654345,Antibacterial activity against Pseudomonas aeruginosa NY215 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322913,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
21950,,5167028,CHEMBL1654346,Antibacterial activity against Pseudomonas aeruginosa NY217 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322913,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
21951,,5167037,CHEMBL1654347,Antibacterial activity against Pseudomonas aeruginosa NY219 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322913,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
21952,,5167046,CHEMBL1654348,Antibacterial activity against Pseudomonas aeruginosa NY220 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322913,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
21953,,5167553,CHEMBL1664203,Antimicrobial activity against Bacillus subtilis PTCC 1023 by conventional agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649349,Eur J Med Chem,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1324269,=,1,1,=,MIC,ug.mL-1,0.195,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.195
21954,,5167554,CHEMBL1664204,Antimicrobial activity against Corynebacterium glutamicum ATCC 13032 by conventional agar-dilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649349,Eur J Med Chem,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1324269,=,1,1,=,MIC,ug.mL-1,0.391,CHEMBL614979,Corynebacterium glutamicum,Corynebacterium glutamicum,1718.0,,MIC,ug ml-1,UO_0000274,0.391
21955,,5167555,CHEMBL1664205,Antimicrobial activity against Escherichia coli ATCC 8739 by conventional agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649349,Eur J Med Chem,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1324269,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
21956,,5167556,CHEMBL1664206,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 by conventional agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649349,Eur J Med Chem,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1324269,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.003
21957,,5167561,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,8.0
21958,,5167569,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,8.0
21959,,5167577,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,8.0
21960,,5167585,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.12
21961,,5167593,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.5
21962,,5167601,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC50,ug ml-1,UO_0000274,0.25
21963,Not Active,5167609,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1327195,,1,0,,MIC90,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,,,
21964,,5167617,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,8.0
21965,,5167625,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,8.0
21966,,5167633,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,8.0
21967,,5167641,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,0.5
21968,,5167649,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC90,ug ml-1,UO_0000274,8.0
21969,,5167656,CHEMBL1667176,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
21970,,5167664,CHEMBL1667177,Antibacterial activity against Staphylococcus haemolyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,40.6,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,40.6
21971,,5167672,CHEMBL1667178,Antibacterial activity against Staphylococcus hominis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,32.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,32.0
21972,,5167680,CHEMBL1667179,Antibacterial activity against Staphylococcus lugdunensis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,73.3,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,73.3
21973,,5167688,CHEMBL1667180,Antibacterial activity against Staphylococcus saprophyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,100.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,Activity,%,UO_0000187,100.0
21974,,5167696,CHEMBL1667181,Antibacterial activity against Staphylococcus warneri assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,76.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,Activity,%,UO_0000187,76.0
21975,,5167704,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
21976,,5167712,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
21977,,5167720,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC,ug ml-1,UO_0000274,0.06
21978,,5167728,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
21979,,5167736,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.25
21980,,5167744,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
21981,,5167752,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,0.12
21982,,5167760,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
21983,,5167768,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,0.25
21984,,5167776,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
21985,,5167784,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,0.25
21986,,5167792,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
21987,,5167800,CHEMBL1667182,Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,100.0
21988,,5167808,CHEMBL1667183,Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,98.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,98.0
21989,,5167816,CHEMBL1667184,Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,98.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,Activity,%,UO_0000187,98.0
21990,,5167824,CHEMBL1667185,Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,98.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,98.0
21991,,5167832,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
21992,,5167839,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
21993,,5167846,CHEMBL1667186,Antibacterial activity against levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,93.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,93.8
21994,,5167853,CHEMBL1667187,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,1327195,=,1,0,=,Activity,%,1.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.2
21995,,5167860,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
21996,,5167867,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,32.0
21997,,5167874,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
21998,,5167881,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,64.0
21999,,5167889,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327195,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
